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3 ABBREVATIONS 
 
BAC – Bacterial Artificial Chromosome 
BLAST – Basal Local Alignment Sequence Tool 
BN rat – Brown Norwegian, rattus norvegicus 
CD – Cluster of Differentiation / Cluster Designation 
CLSF – C-type Lectin like Super Family 
CMV – Cytomegalo Virus 
CRD – Carbohydrate Recognition Domain 
CTLD – C-Type Lectin like Domain 
EBV – Ebstein Barr Virus 
GE – Gele electrophoresis 
GM – CSF Granulocyte and Macrophage Colony Stimulating Factor 
HCV – Hepatitis C Virus 
HSV – Herpses Simplex Virus  
IFN-γ – Interferon gamma 
Ig – Immunoglobulin 
IL – Inter Leukin 
ILT – Ig-like transcript 
ITAM – immunoreceptor tyrosine-based activating motif 
ITIM – immunoreceptor tyrosine-based inhibitory motif 
KIR – Killer cell Ig (immunoglobuline) –like receptors 
KLR – Killer cell Lectin like Receptors 
LAIR – leukocyte-associated Ig-like receptor 
LAK – Lymphokine Activated Killer cells 
LGL – Large Grranulated Lymphocyte 
LILR – Leucocyte Ig-like receptors 
LRC – Leukocyte Regulatory gene Complex  
MHC – Major Histocompatibility Complex 
MICA/B – MHC class I chain related A / B 
MIP 1 α/β – Macrphage Inflammatory Protein 1α and 1β 
MIR – Monocyte / macrophage immunoglobuline-like receptor 
NCBI – National Center for Biothechnology Information 
NK 1 – NK cell secreting IL10, -12 and IFN-γ 
NK 2 – NK cell secreting IL4, -5 and -13 
NK cell – Natural Killer cell 
Nka – Natural killer alloreactivity  
NKC – Natural Killer cell gene Complex 
NKLLR – Natural Killer cell Lektin-Like receptors 
PAC – P1 derived Artificial Chromosome 
PCR – Polymerase Chain Reaction 
PLC – Phospholipase C 
RANTES - regulated on activation normal T-cell-expressed and secreted 
RT – Reverse Transcriptase 
SH2 – Src Homology 2 domain 
TNF-α – Tumor Necrosis Factor alpha 
ULBP – UL16 binding protein  
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4 INTRODUCTION 
 
Almost six years ago I started to work at the Immunobiological Laboratory (IBL) as a Norwegian 
Research Council student fellow followed by a fellowship in the Norwegian Cancer Society. My 
project was to make a high resolution physical map of the rat Natural Killer cell gene complex 
(NKC). At that time the NKC were thought to span ~800 kb and contain in the order of 20 genes. 
The project was more demanding than anticipated and we now know that the rat NKC is about 
four times bigger, spanning ~ 3.3 Mb and containing 67 genes, all but one encoding related 
proteins, the exception is a GABA receptor. Here I describe the gene content of the distal third of 
this complex, the Ly49 region.  
 
As part of my project I PCR-scanned a PAC library (in collaboration with The Wellcome Trust 
Centre for Human Genetics, University of Oxford) and identified PAC (P1 derived artificial 
chromosome) clones containing NKC genes, and arranged these into a tailing pattern to establish 
the physical chromosomal orders of the genes. The same pattern is seen in figure 7 using BAC 
clones instead of PAC clones. Specific PCR primers for the genes were already available from 
earlier work in the laboratory. The next step was to establish a high resolution physical map with 
regards on the nucleotide sequence and we began sequencing three of the PAC clones. At the 
time we got the sequences, the rat genome project had started and went much faster than foreseen. 
We therefore stopped sequencing more PAC clones and based our mapping on the BAC clone 
sequences and later the whole rat genome sequence released from the rat genome project (based 
on the BN rat strain). It should be emphasized that the rat genome sequence is based on work 
done by robots, automatic sequencers and computers, with little human intervention, and it is up 
to the scientific community to characterize the sequences deposited in the databanks. Identifying 
genes from these sequences is often referred to as “in silico cloning”. Before they can be 
publihsed, however, in silico cloned genes have to be verified by in vitro cloning. We have so 
fare done both and the work here reported is therefore a combination of mapping of Ly49 genes 
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already cDNA cloned in our laboratory, and in vitro cloning of new genes in silico predicted from 
the genome sequence. 
 
The Ly49 receptor family makes up a cluster of genes in the distal part of the NKC and encode 
type 2 transmembrane receptors expressed by natural killer (NK) cells and a subset of T cells. 
The NKC is located on the rat chromosome 4q42, the mouse chromosome 6F3 and on the human 
chromosome 12p13.31. In the rat the Nka, autosomal dominant locus controlling NK-mediated 
alloreactivity, is mapped to the distal part of the Ly49 region. The receptors belong to the C-type 
lectin superfamily (CLSF), are involved in NK cell recognition of target cells and influence the 
NK cell activity. The Ly49 receptors come in two functional forms, activating and inhibitory, 
where both forms are expressed on the NK cell. Whether the NK cells shall recognize another cell 
as a target to be killed, or as not a target to be spared, depends on integration of the signals 
transmitted by the opposing receptors. In the mouse and the rat there are many different Ly49 
receptors among the two types. Here I report the cloning of new Ly49 receptor genes in the rat, 
describe how they are organized in the genome and discuss the evolution of the rat Ly49 receptor 
repertoire. First I shall give some background information on NK cells and the C-type lectin-like 
receptors.  
 
4.1 Natural Killer cells 
4.1.1 Definition, morphology and distribution 
In 1975 Kiessling and co-workers discovered a population of murine splenic lymphocytes that 
could kill malignant cells in vitro without prior sensitization. The lytic activity was shown to be 
non-MHC restricted and to be performed by a cell type unknown at the time. The cells were 
therefore called Natural Killer (NK) cells. In the microscope they looked like lymphocytes, but 
with scattered large granules, and were accordingly also referred to as “Large Granulated 
Lymphocytes” (LGL) 1 as can be seen in the picture below, figure 1.  
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Figure 1 
Large Granulated Lymphocytes – NK cells. Kidney shaped 
nuclei and azurophilic granules in the cytoplasm. 
Compared with resting T and B cells, LGL are 
larger and with a higher cytoplasm/nucleus ratio. 
The nucleus is kidney shaped and the cytoplasm 
contains azurophilic granules. NK cells share 
many of the surface markers with T and B cells, 
e.g. CD2 on NK and T cells. In the human NK 
cells are defined by the expression of NKR-P1 and 
the lack of CD3 2.  
 
NK cells belong to the lymphocyte linage 3. In contrast to T cells, NK cells are short-lived with an 
approximate life span of 1-2 weeks. The NK cells are divided into two subgroups, NK1 and NK2, 
depending on cytokines secreted, see 2.2.4 page 11. NK cells are found in the blood where they 
constitute approximately 5-20% of the lymphocytes, in the liver (pit cells), the red pulp of the 
spleen (where they constitute approximately 5% of the lymphocytes), the alveolar capillaries in 
the lung and in the uterus. In contrast to T cells NK cells do not recirculate between blood and 
lymphoid organs 4.  
 
4.1.2 Functions 
Together with granulocytes and macrophages, NK cells constitute the effector cells in the innate 
immune system. Through cytokine release, like IFN-γ and TNF-α, they have influence on the 
adaptive immune system. NK cells can be activated and migrate to sites of infection, where they 
proliferate, release cytokines and kill cells harbouring pathogens5. This process is initiated by 
activating receptors leading to expression of receptors like chemokine- and cytokine receptors 
which induce chemotaxis and activation of the NK cell. The NK cells recognize their targets by 
detecting abnormal protein expression patterns, like altered levels of MHC–I or related 
molecules, on the target cell surface. They are able to detect and eliminate some tumor cell types, 
 9
some types of infected cells and allogenic cells. Killing is mediated by two different mechanisms: 
1) sercretion of perforin and granzymes from intracellular granules and 2) expression of Fas 
ligand. The end point is cell membrane destruction with cellular lysis or induction of apoptosis 
respectively.   
 
4.2 NK cells and their targets 
4.2.1 Allogenic cells 
Cells that do not express the correct amount or type of MHC class I molecules are susceptible to 
NK cell killing 6. Host NK cells thus recognize and eliminate transplanted MHC incompatible 
allogeneic cells. The evolution of the alloreactivity recognition system may seem puzzling 
considering that natural transfer of allogeneic cells would be expected to occur only rarely. 
However, in mammals fetal semiallogeneic cells are in close contact with the maternal blood 
circulation (spiral arteries in the decidua) and may easily invade the mother if not kept in check.  
NK cells are thought to play a role in spontaneous abortion. Large colonies of NK cells are 
localized in the decidua and probably take part in the process of fetal rejection 7. Pregnancy is 
therefore one possible reason why this surveillance system has developed and sustains.  
 
4.2.2 Cancer cells 
Because NK cells were first detected through their ability to kill tumor cells, they were postulated 
to play a role in the restriction of primary tumor formation and metastases development. At the 
present antigens presented on tumor cells are neither fully characterized nor understood. Tumor 
cell MHC class I and class I related molecules seemed to play a role in recognition and induction 
of tumor cell killing. A tumor cell presenting an altered pattern of self – MHC classes may shift 
the balance from not kill to kill due to integration of activating and inhibiting NK cell receptors. 
MICA and MICB (MHC class I chain related A and B) are molecules that resemble the MHC 
class I and are expressed by some epithelial tumors. In the human the NK cell receptor NKG2D 
recognize MICA and MICB, and binding of NKG2D to these ligands results in enhanced NK cell 
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activity and killing of the tumor cells 8. Additional receptors in the human that recognize tumor 
ligands and lead to enhanced killing are the NKp30, NKp44, NKp46 and CD16 9.  
 
4.2.3 Infected cells 
NK cells recognize and kill cells infected by cytomegalovirus (CMV), Epstein-Barr virus (EBV) 
and herpes simplex virus (HSV). In addition NK cells possess the property of chemotaxis, which 
result in cellular movement towards the site of infection 5. For detection of intracellular parasites 
mammals have developed a sophisticated report system whereby MHC class I molecules sample 
peptides resulting from partial degradation of proteins synthesized intracellularly and bring these 
to the cell surface for inspection by CD8+ T cells. If the T cells recognize foreign peptides on the 
surface of a cell, signifying intracellular parasites, the cell is killed. Some viruses are able to 
interfere with this report system. By downregulating MHC class I expression they evade detection 
by T cells and killing. In this context, the NK cells constitute a back-up system which detects and 
eliminates cells with low or no MHC class I expression.  
To evade killing by NK cells some viruses, like the cytomegalovirus, hinder down regulation of 
particular inhibitory MHC I ligands 10 and some even encode MHC class I protein analogues 
which are expressed and act as decoys on the surface of the infected cells. Another example on 
the race-of-arms between parasite and host is the infection with hepatitis C virus 1 (HCV-1), 
which leads to expression of HCV-E1, a ligand for the CD81 NK cell receptor.  
HCV-E1 bound to the CD81 receptor leads to blocked NK cell activation, reduced cytokine 
production, reduced cytotoxic granule release and inhibition of NK cells proliferation 11. 
 
Detection of reduced levels of MHC class I on target cells depend on inhibitory NK cell receptors 
for these ligands. A significant lowered inhibitory signal via inhibitory receptors will lead to loss 
of inhibition and hence activation of the cell. However, the NK cells also have at its disposal 
activating receptors such as NKG2D, Ly49s3 and NKp46, which upon ligation induce 
cytotoxicity, proliferation and cytokine production. A human cell infected by CMV upregulates 
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membrane molecules like MICA, MICB, ULBP1/2/3 that are ligands for the activating NK cell 
receptor NKG2D leading to increased cytotoxicity and killing. Some viruses encode proteins that 
can interfere with the NK cell recognition by the activating receptors. An example is UL16, an 
early protein transcribed from the hCMV genome, which binds to and blocks the interaction 
between ULBP1/2 or MICB and NKG2D 12 and thereby hinders killing of the cell. 
 
4.2.4 NK cells and immunomodulation 
Via activating receptors and cytokines the NK cell can recognize structures induced on infected 
or stressed cells leading to target cell lysis, NK cell proliferation and production of cytokines and 
chemokines such as INF-γ, TNFα, GM-CSF, MIP-1α /1β and RANTES 13. INF-γ produced by 
NK cells leads to a variety of effects, such as inhibition of virus replication, induction of nitric 
oxide synthase (iNOS) by macrophages and induction of MHC I expression in macrophages, 
thereby augmenting presentation of virus peptide to the cytotoxic T cells. As previously 
mentioned there are two different subsets of NK cells based on the production of different sets of 
cytokines: 1) NK1 cells secreting IL-10, IL-12 and INF-γ; and 2) NK2 cells secreting IL-4, IL-5 
and IL-13 14. 
 
4.2.5 The cytotoxic mechanisms 
Two killing mechanisms are used by the NK cell 1) induction of cell lysis and 2) apoptosis.  
1) Lysis of a target cell is mediated by the release of granzymes and perforin by exocytosis of 
cytotoxic granules within the NK cell. Granzymes belong to a family of serine proteases involved 
in the lytic activity, where for example granzyme B promotes DNA fragmentation and is involved 
in cell death. Perforin is a pore-forming protein which leads to death by making the cell 
membrane leaky, but it is not fully established whether the cell death is caused by membrane pore 
formation or endosome permeabilization 15.  
2) Apoptosis, programmed cell death, is induced via binding of Fas ligand on the target cell to the 
Fas receptor on the NK cell 16,17.  
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NK cell killing can be understood as a shift in the balance between activation and inhibition, 
either loss of inhibitory receptors or a gain in activating receptors. Examples of activating 
receptors are Ly49s3 in the rat and NKG2-D, NKp30, NKp44 and NKp46 in the human, and 
inhibitory receptors Ly49i2 in the rat and NKRP-1a in the human.  
When killing is initiated the NK cell becomes polarized where the cytolytic granules that 
are released via exocytosis upon ligation to a target cell are directed to the part of the 
membrane in contact with the target cell, and the receptors involved in apoptosis are 
organized on the cellular surface toward the target cell. This area of contact between 
target and “killer” is referred to as the immunologic synapse. Binding and activation of 
different receptors (immune receptors, costimulatory- and cytokine receptors) lead to 
phosphorylation of intracellular proteins and rearrangement of the cytoskeleton 18, which 
is a prerequisite for directing the cytotoxic granules towards the immunologic synapse. 
Conversely, when inhibitory signals dominate, the activating signal pathways are blocked 
by phosphatases, leading to dephosphorylation, dormant NK cell and no exocytosis of 
cytotoxic granules. 
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Figure 2 
A cartoon showing some of the intracellular 
events when a target cell engages with an 
inhibitory NK cell receptor. The ITIM motif 
is phosphorylated by Scr kinases and 
activated, facilitating binding of SHP-1 and 
down stream dephosphorylation of 
intracellular proteins leading to NK cell 
inhibition. 
 
Figure 3 
A cartoon showing some of the intracellular 
events when a target cell engages with an 
activating NK cell receptor. An adaptor 
molecule (green “squash”) with ITAM motif 
is recruited when target cell binds to the NK 
cell receptor. This adaptor protein is linked 
to the activating Ly49 molecule by coupling 
a negatively charged amino acid in the 
adaptor protein to an arginine in the Ly49 
molecule. The ITAM becomes 
phosphorylated and activated leading to Syk 
binding. Syk, a kinase, phosphorylate down 
stream molecules and leads to activation of 
the NK cell and then killing of the target 
cell. 
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4.3 NK CELL RECEPTORS                                                                                                                    
2.3.1 Killer cell lectin-like receptors (KLR) 
Lectins are carbohydrate binding receptors containing a carbohydrate-recognition domain - CRD. 
In vertebrate lectins there are several different types of CRDs. The largest family are the C-type 
lectins (CTLs), so called because the saccharide binding is Ca2+ dependent. CTLs are involved in 
a variety of functions, such as cell adhesion (selectins), glycoprotein clearance and innate 
immunity (collectins). Fourteen different groups of CTLs have been described. CTL group V is 
primarily expressed by NK cells and referred to as killer cell lectin-like receptors - KLR. The 
KLR are atypical in that most of them seem to bind protein ligands instead of saccharides.    
In the human, the rat and the mouse the genes encoding the KLRs are located in a chromosomal 
cluster called the Natural Killer cell gene complex (NKC). In the rat this complex is located on 
the distal part of the long arm on chromosome 4, 4q42. The proteins encoded by this gene 
complex are type II receptors, i.e. single pass transmembrane (TM) proteins with the amino 
terminus located intracellularly. The NKC in the rat contains 67 receptor genes, which can be 
divided into different subfamilies regarding protein structure. Some of these subfamilies contain 
multiple members and others only one gene (such as CD94 and KLRE). Three of the former are 
the NKR-P1, the NKG2 and the Ly49 subfamilies, all of which contain both activating and 
inhibitory receptors. 
4.3.1a NKR-P1 
The molecules constituting this subfamily are disulphide bonded homodimers expressed on both 
NK (CD3-) and a subset of T cells referred to as NKT (CD3+) cells. In the rodents the genes are 
located to the proximal part of the NKC. NKR-P1A and -C mediate activating signals, whereas 
NKR-P1B and -D are inhibitory. In the human only one gene, hNKR-P1A, has been detected 19. It 
putatively mediates activating signals to the human NK cell.  
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4.3.1b NKG2/CD94 
NKG2 members form disulphide bonded heterodimers together with CD94. The heterodimer is 
expressed by NK cells and a subset of T cells in the rat, mouse and human. CD94 is the invariant 
part of the receptor complex whereas there are three different NKG2 members in rodents, both 
activating and inhibitory molecules 20. The inhibitory NKG2A contains an ITIM in the 
intracellular part of the receptor. The ITIM motif is an intracellular protein sequence recruiting 
and activates the scr protein which upon activation leads to intracellular down stream inhibition 
of the NK cell, see figure 2 page 13. On the other hand the activating NKG2C and -E contain no 
ITIM motif but a charged amino acid (lysine) in the transmembrane domain which recruit and 
bind to DAP10. DAP 10 is a membrane bound activating adaptor protein housing an intracellular 
ITAM motif, which lead to activation of the NK cell 21, see figure 3 page 13. 
 
4.3.1c The Ly49 subfamily 
The Ly49 subfamily constitute the largest KLR family in the rat, and seem to form disulphide 
bonded homodimers expressed by NK cells and subsets of T cells 22 23. In the human Ly49L is the 
only Ly49 gene detected which is a truncated not expressed gene 24. In rodents there are multiple 
genes, 34 in the rat (see figure 5) and 23 in the mouse, named Ly49A to Ly49W. The so far 
known ligand for these receptors are MHC class I molecules and MHC class I homologues like 
MICA 25,26.  
 
The inhibitory Ly49 receptor molecules have an ITIM motif in the cytoplasmatic region which 
the activating molecules lack. The activating molecules holds, whereas the inhibitory molecules 
lack, a transmembrane region harbouring a positively charged amino acid. This arginine is the 
link to activation via coupling to an activating adaptor molecule. Following the transmembrane 
region is a stalk separating the ligand binding domain from the cell membrane. The ligand 
binding region within the Ly49 family is the highly conserved C-type lectin-like domain (CTLD), 
shown in figure 4, consisting of two α-helices (α1 and α2), two anti-parallel β-sheets formed by 
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β-strands (β0, β1 and β5) and (β2, β2´, β3 and β4). There are four intrachain disulphide bonds, 
two of which are the characteristic invariant disulphides found in C-type lectins located in 
position C1 and C2, see figure 12. A third disulphide bond is linking strands β0 and β1. The fourth 
is unique to the Ly49 and links the N-terminus of strand β5 to the first turn of helix α1 (Cys167 – 
Cys253 in figure 4) 
The intracellular part (N-terminus) of the inhibitory Ly49 receptors has an immunoreceptor 
tyrosine-based inhibitory motif (ITIM) close to the N-terminus. Upon receptor ligation the ITIM 
is phosphorylated, which leads to downstream inhibition of the NK cell by recruitment of SH-2 
domain containing tyrosine phosphatases or by the lipid phosphatase inositol-5 phosphatase 
(SHIP) 27,28.The activating receptors lacks the ITIM motif, has a shorter intracellular domain and 
has instead arginine, a positively charged amino acid, in the transmembrane domain which 
associates with DAP10, a membrane bound adaptor molecules containing immunoreceptor 
tyrosine-based activating motifs (ITAMs). Upon receptor ligation the ITAMs become 
phosphorylated and recruit downstream Syk or Zap 70 leading to cellular activation 29, see figure 
3. In addition to these two receptor types I have cloned three receptors that contain both an ITIM 
and an arginine in the transmembrane domain. How these apparently ‘bifunctional’ receptors 
work is not known and analyses are about to be started. 
Figure 4 
Ribbon diagram of mouse Ly49A and Ly49I 
To the left the Ly49A is shown with red α-helices, 
blue β-sheets and green disulphide links. To the 
right the Ly49I with red α-helices, green β-sheets 
and violet disulphide links. The conservation of 
3D-structure between Ly49A and Ly49I is evident. 
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4.3.2 Killer cell Ig-like receptors 
The Killer cell Immunoglobulin- (Ig-) like Receptor (KIR) family is characterized by molecules 
having one or several Ig-related domains. The receptors are encoded by genes located in the 
Leukocyte Regulatory gene Complex (LRC) on chromosome 1 in the rat. The LRC is constituted 
by the KIR family, the leukocyte Ig-like receptor (LILR) family, the leukocyte-associated Ig-like 
receptor (LAIR) family, GPVI, Fcα receptor (CD89) and NKp46. Some of these molecules are 
expressed on different cell types, whereas NKp46 is expressed on NK cells only. KIRs are 
expressed on NK cells and a subset of T-cells.  
 
4.3.2a Killer cell Ig-like Receptors (KIR) 
The KIRs are expressed as membrane bound monomer, modulating the NK cytotolytic response 
by either activation or inhibition. Subset of MHC class I molecules seem to be ligand for the 
KIRs. The KIR molecules are immunoglobuline (Ig) holding receptors and are given name 
depending on the number of extracellular Ig domains and the length of the intracellular domain. 
KIR2D members have two and KIR3D three Ig domains. L and S depict whether the KIR 
molecule has a long or a short intracellular domain, respectively. Only one KIR has been detected 
in the rat so far, whereas in the human there are 14 30,31. The long KIRs (L) tend to be inhibitory 
by containing ITIM motifs in the cytoplasmatic region, whereas the short ones (S) have a charged 
amino acid in the transmembrane region associating with DAP12, an activating adaptor protein 
containing an ITAM motif 32. One interesting molecule is the putatively bifunctional KIR2DL4 
that contains both a charged amino acid and an ITIM motive. At present its biological function is 
unknown.  
 
4.3.2b Leukocyte Ig-like receptors (LILR) and leukocyte-associated Ig-like receptor (LAIR) 
The LILR family, also known as the Ig-like transcrips (ILTs), resembles the KIRs, FcαR and  
gp49 33. It also includes the leukocyte immunoglobulin-like receptor 1(LIR-1) which can bind 
UL18, a cytomegalovirus encoded protein which mediate inhibitory signaling via ITIMs  34.  
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The last member is the monocyte/macrophage immunoglobulin-like receptor (MIR) which has an  
ITIM motifs, these receptors are expressed not only on NK cells but also on macrophages, 
monocytes and dendritic cells 35. The activating molecules associate with the FcεRIγ adaptor 
molecule which transmit the activating signal.  The LAIRs are type 1 single transmembrane 
receptors with one Ig domains in the extracellular region and 2 ITIM motives intracellularly. The 
LAIR family consists of two inhibitory members, LAIR1 and LAIR2. LAIR1 is expressed both in 
the human and the mouse, whereas LAIR2 is at present detected in the human only. These 
receptors are expressed on different mononuclear cells, such as NK cells, B cells, T cells, 
monocytes, dendritic cells and thymocytes36.  
 
4.3.2c NKp46 
Due to its expression in all NK cells and NK cells only, NKp46 is a NK cell marker. NKp46 has 
two Ig domains extracellularly and an arginine within the transmembrane domain, hence an 
activating receptor 37. In the rat NKp46 is associated with a heterodimer of CD3ζ and FcεRIγ 
(“Rat NKp46 activate natural killer cell cytotoxixity and is associated with a heterodimer of 
CD3ζ and FcεRIγ, Westgaard, IH – submitted manuscript). 
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Figure 5 – Principles of the PCR method 
 
5 METHODS & TECHNIQUES 
5.1 The polymerase Chain Reaction (PCR) 
PCR is a method for rapid amplification of a specific DNA segments. Briefly, the principle of the 
method is as follows, take also a look at figure 5: The DNA polymerase, which adds nucleotides 
to a new strand using a pre-existing strand as a template, cannot initiate the synthesis of the new 
strand from the start (i.e. cannot prime DNA synthesis), only continue to add nucleotides to the 
tail of partially synthesized strand. The sites from where synthesis occurs on the template are 
thereby determined by where the partially synthesized strands are found. During DNA 
replication, these ‘primers’ are made by an RNA polymerase, called primase. This process can be 
imitated in vitro, by making synthetic oligonucleotides that match specific sites of the template 
DNA, thereby directing DNA synthesis to these sites. A specific DNA sequence is amplified by 
making primers flanking the sequence, complementary to the two antiparallel strands in the DNA 
double helix.   
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In a PCR reaction the following ingredients are added: 1) DNA template, 2) the two primers, 3) 
the four nucleotides as activate triphosphates (dNTPs, where N stands for A, C, G or T), 4) a 
suitable buffer and 5) heat stable DNA polymerase. The template DNA is first denatured, i.e. the 
two stands are separated by heating the PCR mix to 94oC. By cooling the mix down the DNA 
strands start to re-anneal, i.e. the complementary sequences bind to each other. Because the 
primers are in much higher concentrations than the template, the primers bind much more rapidly 
to the complimentary region in the template DNA than the original template strands. Immediately 
following primer binding, the DNA polymerase starts to synthesize a new strand from the 3’ end 
of the primer with the base sequence determined by the template strand (see figure 5). From the 
third round amplification is exponential, so that running 30 cycles results in 228 (= 268 million) 
sequence specific copies. The amplified products are separated by gel electrophoresis and 
visualized by staining with e.g. ethidium bromide, which intercalates with the DNA and fluoresce 
when exposed to UV light (see figure 6, page 23)).  
 
5.2 Gel electrophoresis 
To visualize and quantify small molecules they first ought to be separated which is done by using 
a matrix gel, normally made from agarose or polyacrylamide, and then staining the gel by 
different means. Gel electrophoresis (GE) takes advantage of the migration of charged molecules 
within an electric field, negatively and positively charged molecules migrating towards the 
opposite charged electrode. The gel matrix obstruct larger molecules more than it does small, and 
will separate the molecules on the basis of size; small molecules migrating faster than large. 
Hence molecules of same size and charge migrate and position equally in the gel. Agarose gels 
are used to separate large molecules, like PCR products whereas polyacrylamide gels are more 
used for smaller molecules such as proteins. After separating different molecules within a sample 
by using GE the molecules can be visualized by using a molecule specific staining method. 
Ethidium bromide is one example which stains nucleic acids by intercalating between the nucleic 
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acid molecules and makes it fluorescent when exposed to UV light. Other methods can be applied 
to visualize smaller molecules after they have been transferred to a membrane (blotting). Silver 
staining or Comassie brilliant blue dyes can show proteins, as can antibodies after blotting. Figure 
6 shows an ethidiumbromide stained gel after gel electrophoresis has been run. 
 
5.3 Hybridization 
Hybridization is a method for detecting specific DNA sequences. The principle is complementary 
binding of a certain DNA sequence to a template. It is a method to see if a known sequence 
(query) is present in a sample of DNA. If the query is present within a DNA sample it will bind 
complementary to the template, where it is identical, and this binding can be visualized by 
placing a radioactive sensitive film over the washed and cleaned membrane. Since the template is 
non radioactive whereas the query is, the film will be labelled where the query binds to the 
template only. The sample is usually 1) genomic DNA, 2) cDNA, 3) cDNA cloned into a plasmid 
vector, or 4) genomic sequences cloned into e.g. BAC clones. Ad 1) If the genomic DNA is 
digested with restriction enzymes followed by gelelectrophoresis and blotting onto a membrane, 
the technique is referred to as Southern blotting. Ad 2) If the cDNA is blotted in arrays onto 
filters or glass plates, the technique is referred to as dot blots, macro arrays or micro arrays. Ad 3) 
The cloned cDNA is usually a cDNA library, where the goal is to clone homologous sequences. 
Ad 4) Here the purpose can be to identify BACs containing specific genes, e.g. with the aim of 
finding which genes are mapping together on the chromosomes.  
A probe is needed in order to search for a specific sequence. The probe is a copy of the query and 
is labeled with a substance that can be used for detection, for instance a radioactive tag. The 
template is immobilised on a membrane, which is incubated with the labeled probe and then 
washed (the incubation and washing conditions are collectively referred to as ‘stringency’ - see 
below). The probe will bind to its complementary sequence, if present, and is then visualized. If 
for example a radiolabeled probe is used, the membrane is covered with a sensitive film and the 
binding (and position) of the probe detected. The stringency of hybridization can be altered by 
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using different baking temperature (increase of temperature leads to increase of stringency) and 
salt concentration during washing (decrease in salt concentration leads to increase in stringency). 
 
5.4 TA cloning 
TA cloning is a method to generate copies of a DNA sequence, for instance a PCR product, by 
using a prokaryote host such as E.Coli. The desired DNA sequence is ligated into a cloning vector 
using the mechanisms of A-T complementary binding. Taq polymerase attach adenosine residues 
to the flanking ends of the DNA sequence, these DNA ends can then bind to the complimentary 
thymine residues flanking the cloning sites in a cloning vector. Ligation of the DNA fragment 
into the vector is mediated by a DNA ligase. The vector-DNA-unit is transfected into a bacterial 
host by instabilising the bacterial membrane. This is done by shocking the cells either electrically 
or by heat. Within the vector sequence there are genes coding for antibiotic resistance which will 
lead to a selection of the bacterias containing the vector when it is grown in an antibiotic 
containing LB medium. The bacteria containing the vector are grown over night at 37oC on LB 
medium plates, agar plates containing antibiotics, giving rise to many colonies representing one 
bacterial clone. Vector specific PCR is run on different colonies from the LB plate to check 
which colony representing the starting point sequence. One selects several colonies showing the 
proper PCR results and these are grown in bottles with liquid LB medium added antibiotics, one 
bottle for each colony. In this way the starting point sequence has been cloned and multiplied. 
The next step is to separate the vector-DNA-unit from the bacterial solution, a process that can be 
done in different ways. One method is the use of Maxi-prep preparation kit. 
 
5.5 Fingerprinting 
Fingerprinting is a method to give a hint of the similarity between different DNA sequences by 
exposing the DNA sequences to a combination of restriction enzymes. Two identical DNA 
strands cut with the same restriction enzymes will show the identical pattern when compared on 
the gel after GE. Two partly identical DNA strands will show some similarity and some disparity 
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whereas totally different strands will not share any similar pattern. This is based on the feature 
that similar DNA sequences give rise to the same DNA fragments and gel electrophoresis pattern 
when cut with the same restriction enzymes. 
By cutting a DNA sequence with a set of three or four endonucleases and running the resultant 
product on a gel the resultant product gives rise to a “DNA fingerprint”. 
This can be used to indicate whether different BAC clones (Bacterial Artificial Chromosome, a 
vector capable to carry a DNA fragment up to 250 kbp) share the same DNA sequence and hence 
will be overlapping, see figure 6 below. 
 
5.6 Making a PAC contig – presented in a tailing pattern 
A PAC (P1-derived artificial chromosome) contig is a continuous row of overlapping PAC clones 
representing a segment of the genome. A PAC clone is a vector containing approximately 
130.000 nucleotides from a genome. The PACs are identified by the use of PCR and is then 
organized into a pattern where different PACs containing the same sequence is overlapping. By 
running PCR on many different PACs one can establish a contig of overlapping PACs making up 
a tailing pattern. I did this on PACs sent from The Welcome Trust Centre for human genetics by 
using NKC marker specific PCR primers and built up a contig representing the NKC in the rat. 
The same can be done on BACs (Bacterial Artificial Chromosomes), but this time it is done 
electronically, see next chapter and figure 7. 
Figure 6 – DNA "fingerprinting".  
Different ladders in lanes 17, 18, 36, 37, 38. Note the 
similarity between lane 21, 22 and 23, implying that 
these three clones contain some of the same DNA 
sequences and is overlapping  
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5.7 Chromosomal mapping and bioinformatics 
The sequencing of the rat genome, The Rat Genome Project, has been an international 
collaboration where the resultant, fully sequenced rat genom, generated from the BN strain, is 
available on the internet site “Ensembl” (http://www.ensembl.org/Rattus_norvegicus/). On this 
site the chromosomal localization of genes can be done by performing a pairwise blast with a 
query DNA sequence against the whole BN rat genom. An exact position of the query within the 
sequenced genome will be given. The position is given by chromosomal numbering and the exact 
base pair position relatively from the first chromosome base pair. A single search gives rise to 
several hits within the genome, some identical sequences and others just sharing spares similarity, 
to segregate the hits the resemblance between the query and the genome is indicated by 
percentage similarity. Because this site is under continuous upgrading the exact position within 
the chromosome vary depending on when the blast is performed. Another recurring problem is 
the gaps within the sequence. These gaps are of different size and one consequence of the gaps is 
that these might harbor sequences that are genes. 
 
BAC clones containing pieces of the BN genome are shot-gun sequenced and build up to overlap 
and cover the whole BN strain genome. These clones are available via the “NCBI Blast 2 
sequences site” and can be used to build up a contig. The contig will establish the consecutive 
order of the genes on basis of what genes are located within which BAC clone when there is a 
BAC clone overlap along the genome, see figure 7. 
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6 RESULTS 
Six rat Ly49 genes (cDNA) had previously been published (the new names): Ly49-9 (i1), -12 
(s2), -19 (p8) and -29 (s1, from the F344 rat strain) 38 and Ly49i2 39 and Ly49s3 (from the PVG 
rat strain) 40 (all from IBL in collaboration with Veterans Administration Medical Center and 
University of California, San Francisco). In addition, Christian Naper had cloned, but not yet 
published, another seven rat Ly49 genes, provisionally called -i5, -s5, -7 (i6), -19P (s7), -29P (s4), 
-30 (i8) and -35 (i4, from the PVG strain). In all 13 rat Ly49 genes had been cloned, four from the 
F344 and nine from the PVG strains. I have screened the released genomic sequences (both 
individual BAC clones and the assembled whole rat genome sequence) with these cDNA 
sequences in order 1) to identify their chromosomal positions, and 2) to find novel Ly49 genes. 
To the extent that novel genes have been found, I have then tried to cDNA clone these in vitro. In 
the following, I shall briefly describe my findings. The gene nomenclature is based upon the 
receptor function of the specific Ly49 molecule and when they were identified, giving the first 
identified activating/stimulatory molecule the name s1. The receptor function is denoted with 
either s – stimulatory, i – inhibitory or si – bifunctional. As will be shown, 21 new Ly49 genes 
were identified. Of these, I have cDNA cloned five new genes. Nine of the genes are predicted to 
be non-functional in the BN strain. In the following these findings will be presented in more 
detail, including analysis of the sequences with respect to predicted functional properties of the 
receptors and the evolution of this gene complex. 
 
6.1 Identification of Ly49 genes from the genomic sequence 
New Ly49 exons were identified by similarity search (blasting) BAC clones (paired blasts) and 
the whole genome sequence with previously sequenced Ly49 cDNA sequences, a process called 
in silico cloning. Exon-intron splice junctions were deduced by using information from the 
already existing Ly49 molecules, contiguous exons joined and the resulting sequences translated 
and compared with previously known proteins. Sequences contiaining all six coding exons giving 
complete open reading frames were defined as candidate functional genes. Sequences with 
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nonsense (stop codons) or frameshift mutations or lacking exons were considered likely to be 
pseudogenes. Primers were constructed from the putative 5’ and 3’ untranslated regions of the 
candidate functional genes and used for RT-PCR on mRNA isolated from DA or PVG LAK cells 
(lymphokine activated killer cells, i.e. NK cells cultured for ~10 days in the presence of 
interleukin-2). The PCR products were analyzed by gel electophoresis. Bands of expected lengths 
were excised form the gels, amplified by TA cloning (see Methods & Techniques, page 22) and 
the inserts sequenced form both ends in Germany at the Medigenomix. In this way the following 
five new genes were cDNA clones (rat strains from which they were cloned in parenthesis): 
Ly49si2 (DA and PVG), Ly49si3 (PVG), Ly49si1 (DA), Ly49i3 (DA) and Ly49i7 (DA). 
 
6.2 High resolution physical map 
Before the whole rat genome sequence was released in year 2003, I made a high resolution map 
of the Ly49 genes as deduced from overlapping BAC clones arranged in a tiling pattern, as 
shown: 
 I13 P1 i12 i11 si1 si3 si4 si2 i10 si5 I9 p4 s5† i5 s2 s6 s4 
  * Ψ * * * Ψ   * *   *   * * Ψ Ψ * * * * 
BAC-klon                       
AC121471 Y Y N N N             
AC111574 Y Y Y G G Y N N          
AC130159 N N Y Y Y Y Y N N N        
AC114442   N N N Y Y Y Y Y Y N N N    
AC134637     N N N N N Y Y Y Y N N   
AC119655          N Y Y Y N N N  
AC125741          N N Y Y Y Y N N 
AC123191             N N Y Y Y 
                  
 
 s4 I4 p5 p6 p7 i3 p8 i2 p9 i6 S8 S7 i7 s1 i7 i8  
 * *  ψ   ψ   ψ * ψ *   ψ * * * * * * *  
                  
AC123191 Y Y N N              
AC111979 N Y Y Y Y Y Y N          
AC127950  N N N Y Y Y Y N         
AC103500     N N Y Y Y Y N       
AC113919        N N Y Y Y N N    
AC097052          N Y Y Y Y Y N  
AC110487          N N Y Y Y N N  
AC136029            Y Y Y Y N  
AC136574                Y  
 
Figure 7 
Map of the Ly49 gene 
region as deduced from 
overlapping BAC 
clones  
The BACs sequenced by 
the rat genome consortium 
are from the BN strain. 
Their names are shown in 
the first column. The Ly49 
genes are lined in order at 
the top. The horizontal 
yellow lines represent each 
BAC with its 
corresponding genes. Y 
(yes) means that the gene 
is present in that clone, N 
(no) that it is absent, G 
(gap) that there appears to 
be a gap in that particular 
clone (AC111574). i =  
predicted inhibitory 
receptor, s = stimulatory 
(activating) molecule, b= 
bifunctional molecule and 
ψ= pseudogene. 
 † = pseudogen in the BN, 
functional in the PVG (s5).
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Figure 8 
High resolution map of Ly49 region of the NKC as deduced from the rat genome sequence (Ensembl release 
19.3b.2 - February 2004) 
Arrows indicate gene orientation with length of the arrows corresponding to 20 kb. Vertical boxes represent individual exons 
with the width indicating exon length. The numbers below each box indicate positions of exon1 for each gene to be added to 
the number to the left (e.g. Ly49i13 at position 167 Mb + 425 kb = 167 425 kb from the centromere). * exon 6 cannot be 
localized in the Ensembl genome and the internal distance between exon 5 and 6 is estimated to 9 kb.  -: inhibitory, +: 
activating, +/-: bifunctional, gf: gene fragment, p: pseudogene. 
After assembly of the whole rat genome sequence the various Ly49 sequences were blasted 
against this sequence and their consecutive positions and orientations identified, as shown in the 
figure below. The top line represents the whole natural killer cell gene complex, which is seen to 
span ~3.3 Mb. The Ly49 (KLRA) gene region is situated in the distal part of the NKC, is the 
largest cluster within the NKC and makes up slightly more than half of the gene complex in total. 
Protein sequence comparison of all the Ly49 molecules lead to division of the gene complex into 
three major blocks containing multiple closely related genes, with three genes falling outside the 
blocks, Ly49i13, -i6 and i8 from proximal to distal location (see figure 8). There is almost 
absolute colinearity when comparing the physical map with the BAC contig, 
6.3 Cluster size and gene density  
With the exceptions of Ly49s6, which seems to lack exon 3, encoding the membrane proximal 
stalk, and Ly49i8, which has an additional exon of 21 bp (corresponding to 7 amino acids) 
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between exon 1 and exon 2, all the other Ly49 receptors are encoded by 6 exons: exon 1 encoding 
the cytoplasmic part, exon 2 the transmembrane domain, exon 3 the membrane proximal stalk and 
exons 4 to 6 the lectin-like domain.  
 
The Ly49 cluster spans 1,766 Mb from one end to the other. The average length of an open 
reading-frame Ly49 gene is 21.3 kb [range 11,1kb (si1) to 32,2kb (Ly49i8)]. The median distance 
between two consecutive genes (exon 1 to exon 1) is 51 kb (mean 73,8 kb). The central third of 
the complex has the highest gene density - 2,25 genes per 100 kb, whereas the corresponding 
figures are 1,77 and 1,79 for the proximal and the distal thirds, respectively. 
All of the Ly49 genes are encoded by the minus strand (i.e. exon 6 is located proximal to the exon 
1) and thus have the same orientation. For all the genes intron 5, separating exons 5 and 6, is by 
far the largest, usually > 5000 nucleotides and in some cases even >10.000 nucleotides separating 
the two exons.    
 
 
 
 
 
 
 
 
 
 Figure 10 – Distribution of intergenic distances 
Distributions of distances between start codons of 
contiguous genes.  
Mode between 30 and 40 kb, median 48 kb and mean 
51,7 kb. 
Figure 9 – Distribution of gene lenghts 
The lengths of the Ly49 genes, including introns, as measured by the 
genomic distance between the start and stop codons. Mode x ε 
[19,22>kb, median 20,9 kb and mean 21,3 kb. 
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6.4 Sequence analysis  
The Ly49 molecules are very similar concerning nucleic acid sequences and protein structure. 
Here I will comment on some of the variant features among the members. Amino acid alignment 
of exons 1 and 2 for all the genes are shown below in fig.8. Inhibitory Ly49 receptors have an 
ITIM motif intracellularly, characterized by the amino acid sequence I/VxYxxV/L (I=isoleucine, 
V=valine, Y=tyrosine and x=any amino acid). Activating Ly49s have a positively charged amino 
acid (arginine - R) in the transmembrane domain, recruiting an activating adaptor molecule 
holding an ITAM motif by binding to a corresponding negatively charged amino acid in the 
transmembrane domain of the adaptor. Five of the receptors exhibit both features and are 
therefore referred to as bifunctionals. To what extent these are activating or inhibitory (or both) is 
presently unknown. Ly49i8 has the most deviant sequence, including an extra exon (exon 1b), 
encoding 7 amino acids, inserted between exons 1 and 2.  In the genomic sequence this extra 
exon 1/2 lies 780 bp downstream of exon 1 and 655 bp upstream of exon 2.   
 
Use figure 4, 11 and 12 to get a visual impression of the molecule. The lectin domain starts with 
an α-helix (α1), followed by a β-sheet, (β1), via a connecting strand. There is a cluster of acidic 
amino acids (aspartic acid - D or glutamic acid - E) at the end of exon 4 of all the receptors except 
Ly49s6, which lacks the five last amino acids. The conserved WIGL motif (aa210-213), follows just 
after the β2-strand. The first isoleucine and the second valine are in some molecules substituted 
with equivalent hydrophobic amino acids, valine and serine/phenylalanine respectively. The next 
β-strands, β3-5, are encoded by exon 6. The Ly49 lectin domain is characterized by two S-S 
bonds connecting the α1 helix to the β5 strand. Ly49i8 may have a third S-S bond here.  Another 
striking novel observation is that eight of the predicted Ly49 receptors have a conserved cysteine 
residue at the end of exon 6, in position C279, which would be expected to face an extra cysteine 
residue in the beginning of exon 4, in position C142, found in these receptors only at base of the 
lectin domain, with the two probably forming en extra disulphide bridge (the positions marked 
with ▼1 in the alignment). 
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EXON 1          I                                             EXON 2 
              V/IxYxxV/L                                                       R 
s5        MSEQE VPCSTV RFKKSSGLRYQVRPKETQRPREAGCR.           ..VPWQLTVIAIGILLSLRLVAVAMLVTNI 
p4        MSEQE VPCSTV RIKKSSGLRYQLRPKETQRPREAGCRV           CSVPWQLTVIATGILLSLRLFAVAMLVTNI 
i4        MTEQE VTYTTV RFHKSSVFQNKVRSEDTRSAKENGHRE           SSVPWKLIVIALGILCSVLMVTVAALVTNI 
i3(DA)    MTEQE VTYTTV RFHKSSVFHNKVRSKETLSAKENGHRE           SSVPWKLIVIALAILCSVLMVTVAALVTNI 
s3        MSKQD VPCSTV RFKKSSGLQYQVRPEETQRPREAGWR.           ..VPWQLTVIATGILLSLRLVAVAMLVTNI 
i5        MTEQE VTYTTV RFHKSSVFQNEVRSEETQSAKEIGHRE           SSVPWKLIVIALGILCLLLLVTVAVLVTNI 
i2        MTEQE VTYTTV RFHKSSVFQNEVRSEETQSAKEIGHRE           SSVPWKLIVIALGILCSVLLVTVAVLVTNC 
s6        MSKQD VPCSTV RFKKSSGLLYQVRPEETQRPREAGCR.           ..VPWQLTVIAIGILLSLRLVAVAMLVTN. 
si5       MSEQE VSYSNV RFQKCSGLQNQVRPEETQRARAAGHRE           RSVPWQIAVVALVILCSLRLVAVAMFVTKI 
si1(DA)   MSEQE VSYSNV RFKKCSGLQNQVRPEETQRARAAGHRE           RSVPWQLIVVALVILCSLRLVAVAIFVTNI 
i9        MSEQE VTYSTV RFKKSSEMQNQVRPKEPQRPREAGHRE           SSVPWQLIVIALGILCSLLLVTVAVLLTKI 
i10       MSEEE ITYSTV RFKISSEVQNQVRPKEPQRTREAVYRE           SSVPWQLIVIALGILCSLLLVTVAVLLTNI 
i11       MSEEE ITYSTV RFQNSSEVQNQVRPKEPQRTRETVHRE           SSVPWQLIVIALGILCSLLLVTVALLLTNI 
si2(PVG)  MSEQE VSYSNV RFQKCSDLQNQVRPEETQRARAAGHRE           RSVPWQLIVVALVILCSLRLVAVVMFVTNI 
si3       MSEQE VSYSNV RFQKCSDLQNQVRPEETQRARAAGHRE           RSVPWQLIVVALVILCSLRLVAVVMFVTNI 
si3(PVG)  MSEQE VSYSNV RFQKCSDLQNQVRPEETQRARAAGHRE           RSVPWQLIVVALVILCSLRLVAVAMFVTNI 
si4       MSEQE VSYSTV RFKKSSGRQNQVRPEETQTAREAGHTE           RSVPWQLIVVALVILCSLRLVAVGMILTNI 
s7        MSEQE VIFSTE RFHKSSGLQNQVRPEETQWSRKAGPRV           CSVPCLLIVIALGI..PLRLVIAAALVSHI 
s1        MNEQE VIFSTE RFHKSSGLQNQVRPEETQSSRKAGPRV           CSVPCLLIVIALGI..PLRLVIAAALVSHI 
s8        MSEQE VIFSTE RFHKSSGLQNQVRPEETQQSRKAGPRV           CSVPCQLIVIALVVLCSLRLVIVAVLVTNI 
i1        MSEQE VTYSSV RFSKSSGLQNQVKPEETKGPKEAGHRE           CYVPWHLIVIALGILCTLLLLTVAVLVTII 
i7(DA)    MSEQE VTYSSL RFSKSSRLHNQVKPEETRGPREAGHRE           CYVPWHLIVIALGILCTLLLVTVAVLVTNI 
i6        MCDQE VTYSTV RFHKSSGLQNQERAEETQGPIEAGHRK           CSVLWQHIKIALGILCSHLLVTLAVLALSI 
s2        MNEQR FTFSTA RFHKSSVLQNQERTEETQRPRKAGNR.           ..VCWQITVTALGILCFFRLVSVAVMVINI 
p8        MNEQR VTFSTA RFHNSSVLQNQERTEGTQRPRKAGNR.           ..VCWQSTVTALGILCSFRLVSVAVLVKT. 
i13       MSEQE VTYSTL RFHNSSGLQNQVKTNETQGPRETGHRG           CSVSWHLIMIPLGILCSILLVTVAVLVTHI 
i8        MSEQE VTYTTV RFHKSPGLQNQVRPEETQRPRKAGHRA  HSECKVR  ECSVTWKPIVIVLGILCSLLLVTVAVLLTHI 
 
Consensus MSEQE VTYSTV RFHKSSGLQNQVRPEETQRPREAGHR-           ECSVPWQLIVIALGILCSLLVTVAVLVTNI 
 
Figure 11 – Exon alignment 
Alignment of peptide sequence encoded by exon 1 and 2  I/VxYxxV in exon 1 represents the ITIM motif (red: inhibitory molecules, violet: 
bifunctional). R in exon 2 (turquoise: activating molecules, violet: bifunctional) represents the arginine involved in the interaction with the 
DAP12 adaptor molecule. Predicted transmembrane region underlined. 
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EXON 4      ▼1         C G  CYY   D   W  C1  C2       L IDDEDEL    EXON 5       W G 
s5         RCVEMHWFCHGIKCYYFIMDIRTWHECKQTCQNYNLSFLKIDDKDEL    KFLQDHIIRDSY WVGL SYNNIKKEWSWIDSSPLNC 
p4         ...............................................    ............ .... ................... 
i4         GCDEMHWFCYGIKCYYFTMDIRIWHECKQTCQNYSLSFLKIDDKDEL    KFLQDHIIRDNY WIGS SYNNKKKEWSWIDNSPFNL 
i3(DA)     RCDEMHWFCYGIKCYYFTMDIRIWRECKQICQNYSLSFLKIDDKDEL    KFLQDHIIRDNY WIGS SYNNKKKEWSWIDNSPFNL 
s3         GCDEMHWFCYGIKCYYFTMDIRIWRECKQTCQNYSLSFLKIDDKDEL    KFLQDHIIRDNY WIGS SYNNKKKEWAWIDNSPFDL 
i5         RCVEMHWFCHGIKCYYFIMDIRTWHECKQTCQNYNLSFLKIDDKDEL    KFLQEHFIRESY WIGL SYNNIKKEWSWIDNSPLNC 
i2         GCVEMHWLCYGIKCYYFIIDKRTWHKCIQTCQNYSLSFLKIHDKDEL    KFLQDHIIRDSY WIGL SYNNNKKEWSWIDNTTLNC 
s6         GCVEMHWLCYGIKCYYFIMDKRTWRKCIQTCQNYSLSFLKIH.....    KFLQDHIIRDSY WIGL SYNNKKKEWSWIDNTPLNC 
si5        QNFEIYWFCYGIKCYYFILDTKAWNGCKQTCQDSSFFLLKIDDEDEL    KFLRLQVLSYQY WIGL SYNKTEKEWSWIDNGQSEL 
si1(DA)    KNVEIYWFCYGIKCYYFILDTKAWNGCKQTCQDSSLSLLKIDDEDEL    KFLRFQVLSDQY WIGL SYNKREKKWSWIDNGQSEF 
i9         KNVEIYWFCYGIKCYYFILDTKAWNGCKQTCQDSSLFLLKIDDEDEL    KFLRLQFLSYQY WIGL SYNKTEKEWSWIDNGQSEL 
i10        KNAEIYWFCYGIKCYYFILDKKTWIGCQQACQKSRLSLLKIDYEDEL    KFLRLQDLSDQY WIGL SYNKAKEEWSWIDNGQSEF 
i11        KNVEIYWFCYGIKCYYFILDKKTWIGCQQACQKSRLSLLKIDYEDEL    MFLRLQVLSDQY WIGL SYNKAKEEWSWIDNGQSEF 
si2(PVG)   KNVEIYWFCYGIKCYYFILDKKTWIRCQQACQKSRLSLLKIDDEDEL    KFLQLQVLSDQY WIGL SYNKAKEEWSWIDNGQSEF 
si3        KNVEIYWFCYGIKCYYFILDKKTWIRCQQACQKSRLSLLKIDDEDEL    KFLQLQVLSDQY *IGL SYNKAKEEWSWIDNGQSEF 
si3(PVG)   KNVEIYWFCYGIKCYYFILDKKTWIRCQQACQKSRLSLLKIDDEDEL    KFLQLQVLSDQY WIGL SYNKAKEEWSWIDNGQSEF 
si4        KNVEIHWFCYGIKCYYFILDKKTWIGCKQACQKSRLSLLKIDEEEEL    KFLRLQVLSDQY WIGL SYNKAKQEWSWIDNGQSEL 
s7         SEIETYWFCYGIKCYYVIKDGKSWDECKQTCQNSSLFLLKIDDEDER    KFLQQQLIPDNY WIGF SYDKEKKEWAWIENGPSKL 
s1         SEIETYWFCYGIKCYYVIKDGKSWDECKQTCQNSSLFLLKIDDEDER    KFLQQQLITDNY WIGF SYDKEKKEWAWIENGHLNL 
s8         SEIETYCFCYGIKCYYVIKDGKSWDECKQTCQNSSLFLLKIDDEDER    KFLQQELIPDNY WIGF SYDKEKKEWAWIENGPSKL 
i1         SEIETYWFCYGIKCYYVIKDGKSWDECKQTCQNSSLFLLKIDDEDER    KFLQQQLIPDNY WIGF SYDKEKKEWAWIENGPSKL 
i7(DA)     NEIETHWFCYGIKCYYFIKDRKTWHGCKRICQNSNLSLLKIDDEDER    KFLQQQVIPDNY WIGL SYEKEKNKWAWIENGPSEL 
i6         KGVKIHWFCYGIKCYYFIMVKKSWNGCQQTCQNSSLPLLKIDHEEEL    KFLQIRVISDNY WIGL KYHNEEKGWAWTDNGESKL 
s2         RGVEMHWFCYGIKCYYFIMDRKTWSGCTQTCQNFSLPLLTIDDEDEL    MFLHLLVTPDSY WIGL SYDNKKSDWTWIDNNPSKL 
p8         RGVEIHWFCYGMECYHFIMDRKTWSGYSQTCQNYSLALLAIDDEDEL    LFLHLLVTPDSY WIGL FYDSTKSDWTWIDNNPSEL 
i13        RQVNVHLFCCGIKCYYFIMDKKQWKECEQACQGCKLSLLTIDDEDEL    KFLQLQVTPDSY WIGL SYDNKKHDSAWIDNNPSN. 
I8         KQVEGHWFCCGMKCYYFITDNVQWNGCKQICQACSLSLLKIDDEDEM    NFLKSQLQGKRY WIGL TYNKSPKKQQWIGDPP.KL 
                -- β0--  -- β1-------  ---α1--            --α2  -----      - β2---  --L1(β) - -L2- 
Consensus  KNVEIHWFCYGIKCYYFIMDKKTW-GCKQTCQNSSLSLLKIDDEDEL    KFLQLQVISD-Y WIGL SYNK-KKEWSWIDNGPSEL 
  
EXON 6                        C3           C3     C1 C2   ▼1   
S5         DLLACKPLQKTGYCIYFSMTGLHYDDCGKRHLCICEKGMDKIPAPLCSVKERSQSAV 
P4         .........................................................  
i4         DFVARNSLRKTGYCMYFSMAGLHDDDCGKRYLCICEKGMDKIPAPLCSVKETSHSAV 
i3(DA)     DFVARTLLRKTGYCLYFSMSGLHDDDCGKRYLCICEKGMDKIPAPLCSVKETSHSAV 
s3         DFVARTLLRKTGYCLYFSMSGLHDDDCGKRYLCICEKGMDKFPAPLCSVKETSHSAV 
i5         DLLACKPLQKTGYCIYFSMTGLHYDDCGKRHLCICEKGMDKITAPLCSVKERSQSAA 
i2         DLVAMISLHKTGNCKYFSMTGLHDDDCGKRHLCICEKGIEKYPAPLCSVKERSQSAL 
s6         DLVAMISLQKTGNCKYFSMTGLNDDDCGKRHLCICEKGIEKYPAPLCSVNERSQSAL 
si5        SLNLKKYNVKDGDCMFLSKTRLENAMCSSPYPCICQKRLDKFPH 
si1(DA)    SLNLKKYNVKDGECMFLSKMRLENAKCMNPFPCICQKRLDKFPH 
i9         SLNLKKYNVKDGDCMFLSKARLENAMCSNPYPCICQKRLDKFPH 
i10        SLNLKKYNEKYGGCMFLSQTRLENTMCMNRYPCICQKRLDKFPH 
i11        SLNLKKYNEKYGGCMFLSQTRLENAMCMNRYPCICQKRLDNFPD 
si2(PVG)   SLNLKKYNEKYGGCMFLSQTRLENAMCMNRYPCICQKRLEKFPD 
si3        SLNLKKYNEKYGGCMFLSQTRLENAMCMNRYPCICQKRLEKFPD 
si3(PVG)   SLNLKKYNEKYGGCMFLSQTRLENAMCMNRYPCICQKRLEKFPD 
si4        SLNLKKYNVKDGDCMFLSKTRLENAMCSNPYPCICQKRLDKFPH 
s7         ASNTMKFNKKLGGCVFLSKTRLDNTDCINLYSCICGKKLNKFPDLLSN 
s1         PSNTMKFNEKLGGCVFLSKTRLDHTDCINLYSCICGKKLNKFPDLLSN 
s8         ASNTVKFNEKLGGCVFLSKTRLDHVDCRNLYSCICGKRLNKFPDLLFN 
i1         ASNTMKFNKKLGGCVFLSKTRLDHTDCINLYSCICGKKLNKFPDLPLQLVLK 
i7(DA)     ASNTKIFNERDGACVFLSKTKLDSIDCNNLYSCICGKRLNKFPDLLFNEC 
i6         VLSRRKFNLKDGGCVFLSKRRLENTKCDNSYSCICGKTLDKFPG 
s2         ALNTRKYNIKDGGCVFLSKTRLDNINCDNLFSCICGKRLDKFPD 
p8         ALNTRKYNVKDGVCVFLSKTRLENINCDYLFNCICGKRLDKFPD 
i13        ALNIKKYYVKDENFVFLSKTRLGNSKRESVYPCICEKRLDKSSNCFSNKS 
i8         DVAGVNLGHDRGNCAFLSSFQIDNEDCAKTCGCICEKRLNIFPILVTCVNQRKQLDLQ SDEGESEEMY LT 
                --L3--  ---β3-- -- β4-- --- β5--------- 
Consensus  -LNLKKYNEKDGGC-FLSKTRLENDDCGNRYPCICEKRLDKFPDPLCSVKERSQSAV- ---------- 
 
Figure 12 – Exon alignment, exon 4 - 6 
Figure representing the exon 4 -6. WxGx representing the WIGL motif, central part of the lectin domain. ▼1 indicate possible site for a disulphide 
binding. Cn indicate disulphide binding within the lectin domain between the same numbers in exon 4 and 6. At the end of exon 6 there is a  conserved 
cluster of acidic amino acids. α and β represent the different helices. L represents the loops within the lectin domain. 
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6.5 Receptor groups and blocks 
To the left is shown a dendrogram of the sequences, where the branching pattern illustrates the 
patterns of sequence similarities. The shorter is a horizontal branch at the end the higher is the 
similarity between the genes. Three major branches 
containing several genes are seen. In addition there 
are four smaller branches, three with only one gene 
(Ly49i13, i7 and i8) and one with two genes 
(Ly49s2 and Ly49p8) four smaller ones are seen. 
Interestingly, the branches coincide with the 
chromosomal gene order, which thereby can be 
defined as consisting of three larger blocks, denoted 
I, II and III in figure 13. Each block contains 
inhibitory as well as activating or bifunctional 
members. Block I lies most centromeric, block II in 
the central part of the complex and block III at distal 
end. To what extent Ly49i13 and –i6 can be 
assigned to a block has not yet been determined.  
 
 
In contrast, Ly49i8 is clearly positioned outside the blocks, at the far distal end of the NKC.   
When comparing mouse and rat Ly49 genes, the rat is seen to have more genes (25 genes with 
open reading frame plus pseudogenes) than the mouse (19 genes). Another striking feature is the 
lack of overlap on a combined dendrogram, see figure 14, with rat Ly49 genes clustering 
separately from the mouse Ly49 genes. There are some exceptions: mouse Ly49Q, which is more 
similar to the rat block I genes than to the other mouse genes, rat Ly49i6, which is more similar to 
the mouse than to the rat genes, and most strikingly, mouse Ly49B and rat Ly49i8, which are 
most similar to each other. The last two genes occupy the same position at the distal end of their 
Figure 13 – Dendrogram of rat Ly49 molecules 
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respective gene complexes. These two genes therefore seem to represent true orthologs, i.e. they 
represent direct descendants from a single gene, with 
sequence differences resulting from speciation. For 
the other genes, the closer intraspecific sequence 
similarities either mean that the genes were 
duplicated after the split between mouse and rat ~40 
million years ago, or that they somehow have been 
homogenized (i.e. made similar to each other after 
speciation), if so, most likely by gene conversion.  
Figure 14 also shows Ly49 genes identified in the 
human (h), baboon (ph), cat (fc), dog (cf), swine (ss) 
and cow (bt). In all of these species only one Ly49 
gene has been identified, and as can be seen from the 
figure, without clear resemblance to a specific rodent 
Ly49 gene. We cannot therefore identify with 
certainty which of the rodent Ly49 genes represent 
the most ancestral gene.   
Figure 14 – Dendrogram of Ly49 molecules from different species 
Dendrogram of all the Ly49 receptors from rat (r), mouse (m), dog (cf - canis 
familiaris), cat (fc - felis catus) , baboon (ph - papyo hamadryos) , human (h) , pig 
(ss - sus scrofa) and cow (bt - bos taurus ). The Ly49 molecules make up families 
which to a lesser extent mix with each other. rLy49-7 is more closely related to the 
mouse molecules and the mLy49Q is more similar to the rat block I. The mLy49B 
and the rLy49-30 make up their own group separated from the other molecules both 
in the mouse and the rat. 
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6.6 Gene homogenization 
Below are dendrograms of exon1 and exon 4 from all the rat receptors, figure 15 A & B. The 
following pattern emerges: Whereas inhibitory receptors tend to cluster separately from activating 
and from bifunctional for exon 1, the pattern is just the opposite for exon 4. Here smaller groups 
are formed, in most cases containing both inhibitory and activating members (or bifunctional 
instead of activating members). The significance of this observation is uncertain. Exon 1 (and 2) 
are involved in signal transduction, whereas exons 4 - 6 most probably are involved in ligand 
binding. The ligands are yet unknown, but as deduced from results in the mouse, probably are 
MHC class I molecules or MHC class I like molecules. It is possible that receptors showing high 
sequence similarity in the lectin domain share ligands. If so, one interpretation of this observation 
is that the grouping together of inhibitory and activating (or bifunctional) reflects a repertoire of 
receptors with opposite signaling functions directed at shared ligands. Why we should have such 
a system is presently unclear. 
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Figure 16 – Dendrogram showing homogenization 
Some molecules show complete exon identity seen in the figure as horizontal lines 
without vertical lines, e.g. exon 4 in Ly49-29 and Ly49-9. (Ly49-9 = Ly49i1, 
Ly49-29=Ly49s1,  Ly49-35 = Ly49i4 and Ly49-36 = Ly49s6)) 
A question is whether this system is based on selective pressure conserving the ligand recognition 
parts of the receptors, or whether it reflects homogenization. In the latter case, on would expect 
that some of the exons from opposing receptors exhibit particularly high sequence similarities. 
This seems indeed to be the case. Figure 16 below shows a dendrograms of all the exons of eight 
selected receptors, four inhibitory and four activating. The complete sequence identities for some 
of the exons bear evidence of relatively recent homogenization events 
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7 DISCUSSION AND CONCLUSION 
In this work I present a high resolution physical map of the Ly49 region of the rat NKC, based on 
the rat genomic sequence. From the rat genome sequence 34 Ly49 genes have been identified, of 
which 7 are predicted to encode activating receptors, 13 inhibitory receptors, 5 bifunctional 
receptors, and 9 pseudogenes. All the genes have the same orientation and are distributed fairly 
regularly along the chromosome, with an average distance of ~52 kb and an average gene length 
of ~ 21 kb. In addition to the new Ly49 cDNAs cloned here, novel findings are:  
1) The presence of five apparently bifunctional Ly49 receptors, never previously described in 
other species (three of which I have cloned), as well as novel sequence features for some of the 
receptors, in particular extra cysteine residues that seem to make additional intrachain disulphide 
bonds.  
2) The number of intrachain disulphide bonds in the lectin domains of Ly49 receptors is higher 
than in other CLSF members. Why these extra stabilizing bonds have been selected for is 
unknown.  
3) The rat Ly49 gene region can be divided into three major blocks encoding related receptors. 
High sequence similarities, even complete sequence identities, indicate extensive occurrence of 
gene homogenization. This seems not to take place between genes in different blocks, only 
between genes within the same block, although the genes can be spaced far apart from each other 
within the block (e.g. si2 and si3 in block I). In order that duplicated genes shall develop into 
separate sequences with different functional properties, it is necessary that homogenization is 
escaped. The NKC must have developed by duplications of a single ancestral gene, whereafter 
separate single and multigene subfamilies were formed. The close sequence similarities forming 
the basis of multigene families may not necessarily represent recently duplicated genes, but genes 
that have not yet escaped homogenization. It is possible that the lack of homogenization observed 
between the three Ly49 blocks is an expression of incipient escape, so that with time the three 
blocks will drift apart into separate subfamilies, but inside each block retains their sequence 
similarities due to continued homogenization. 
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4) Within each block the receptors form smaller groups, showing high sequence similarities of the 
exons encoding the lectin-like domain. As a rule, most of the smaller group contain both 
inhibitory and activating (or bifunctional) receptors, suggesting that the system is designed so that 
the ligands (not yet defined, but probably MHC class I molecules) shall be recognized by both 
types of functionally opposed receptors.    
5) Comparison with mouse sequences gives a picture of a highly dynamic genetic region in rapid 
change. This is supported by comparisons between different rat strains, where e.g the pseudogene 
s5† (see figure 7) in the BN strain probably is the equivalent of Ly49s5 in the in the PVG strains, 
where it seems to be functional (activating).  
 
In conclusion I have cloned cDNA new rat Ly49 receptors, and by sequence and genome analysis 
detected several novel features about this large subfamily of C-type lectin receptors expressed by 
NK cells. The findings should contribute to understanding the evolution and shedding light on the 
function of this group of receptors.   
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Abstract 
We have previously published the cDNA sequences of six rat Ly49 genes and here report 
eleven new genes with full and three with incomplete open reading frames. Although 
obtained from different inbred rat strains (PVG, DA and F344) the cDNAs so far cloned 
seem to represent non-allelic genes as they match with different loci in the BN rat 
genome. The BN rat genome is predicted to contain 34 Ly49 loci distributed over ~1.75 
Mb of the distal part of the rat NK cell gene complex. Some of the cloned genes appear to 
be mutated to non-function in the BN genome, which harbour additional genes with full 
open reading frames. Our analysis indicates that there may be at least 26 non-allelic 
functional Ly49 genes in the rat. Based on deduced amino acid sequences, thirteen of the 
encoded receptors are predicted to be inhibitory, eight to be activating, whereas five may 
be both (‘bifunctional’). Phylogenetic analysis bears evidence of a highly dynamic 
genetic region, where only the most distally localized Ly49 gene has a clear-cut mouse 
ortholog. In phylograms the majority of the rat genes cluster into three larger subgroups. 
The genes within each subgroup map together, defining three chromosomal regions 
which seem to have undergone recent expansions. When comparing only the exons 
encoding the lectin-like domains, the receptors form smaller subgroups, most containing 
at least one inhibitory and one activating or ‘bifunctional’ receptor. The close sequence 
similarities between exons from receptors with opposite signalling functions suggest 
recent homogenization, probably by gene conversion.  
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1 Introduction 
Upon antigenic challenge NK cells respond by releasing cytokines and by killing target 
cells. In addition to eliminating infected and malignant cells, they recognize and kill 
semiallogeneic and fully allogeneic bone marrow derived cells, a feature of uncertain  
physiological relevance, although of clinical importance in bone marrow transplantation. 
To the extent target cell ligands are known, they have in many cases turned out to be 
MHC class I or related molecules. The first MHC class I binding NK cell receptor cloned 
was mouse Ly49A[1]. A plethora of MHC-class I binding NK cell receptors have by now 
been found [2]. They are of two different types: the killer cell lectin-like receptors (KLR) 
and the killer cell and leukocyte Ig-like receptors (KIR and LIR). Both types contain 
inhibitory as well as activating members [3-5], the former with intracellular domains 
containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs), the latter as a rule 
with a positively charged amino acid in the transmembrane (TM) domain mediating 
association with adaptor proteins containing immunoreceptor tyrosine-based activating 
motifs (ITAMs). Following receptor ligation, tyrosine phosphorylated ITAMs recruit 
protein tyrosine kinases [6;7], triggering signaling pathways that activate NK cells. In 
contrast, tyrosine phosphorylated ITIMs recruit and activate the tyrosine phosphatase 
SHP-1 that counteracts the activating signals [8-10]. The KLR are encoded by the natural 
killer cell gene complex (NKC), localized on mouse chromosome 6F3 [11], rat 
chromosome 4q42 [12] and human chromosome 12p13.31 [13]. In the human there are 
many KIR/LIR loci [14], but only a single Ly49 gene, which is mutated to non-function 
[15]. In rodents the situation is reverse, with Ly49 by far the largest subfamily of NK cell 
receptors, and only a few KIR genes [16;17].  
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According to the current BN rat genome assembly (8 Feb 2004), the rat NKC, defined as 
the chromosomal region between Nkrp1b (=Klrb1) and Ly49i8, spans ~3.2 Mb and 
contains 67 KLR genes divided among five multigene families and twelve single genes 
(unpublished). This amounts to all KLR genes hitherto identified , except Klrg1, 
encoding the mast cell receptor MAFA-1 (KLRG1), which lies ~ 7Mb proximal to the 
NKC. Furthermore, it contains no other types of genes, with the single exception of the 
GABA receptor associated protein-like gene, Gabarapl1, which lies in the middle part of 
the NKC, close to Klre1 [18]. All KLR genes, including the Ly49 genes, encode type 2 
single-pass transmembrane disulphide-linked homodimeric proteins with an N-terminal 
C-type lectin-like domain. 
 
In the mouse, the functional gene Cmv1, conferring resistance to cytomegalovirus 
infection, was demonstrated to be associated with Ly49H [19], and Chok, involved in  
recognition of Chinese hamster ovary (CHO) cells, to be associated with Ly49D [20]. In 
the rat, we mapped the alloreactivity gene Nka to the distal part of the Ly49 gene region. 
In the pursuit of the associated structural gene, our wanted to obtain an accurate 
inventory of all rat genes in this chromosomal region, preferably from the inbred PVG 
and DA strains defining Nka [12]. We here report the cDNA cloning of new Ly49 genes 
in addition to the six previously published. Moreover, on the background of the 
seemingly anomalous propensity of rat NK cells to be triggered by alloantigens [12;21-
23], we used the recently released genome sequence of the Brown Norway (BN) rat[24] 
to compare the organization of the rat and the mouse Ly49 gene regions.  
2 Results 
2.1 Gene cloning 
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By in silico homology screening (BLAST) of rat BN BAC clones with the known rat and 
mouse Ly49 cDNAs as probes, 34 putative Ly49 loci were detected and hypothetical 
cDNA sequences constructed from predicted coding exons. Two different strategies were 
used for in vitro cDNA cloning: 1) cloning by RT-PCR on mRNA isolated from PVG or 
DA NK cells, with primers designed from the hypothetical genes identified in silico, 
yielding ten novel cDNAs. 2) in vitro homology screening of a PVG NK cell cDNA 
library with a mixture of previously cloned Ly49 genes as probe, yielding nine cDNAs. 
Eight of these were novel and one represented the PVG allele of the Ly49s2 gene, 
previously cloned in the F344 strain [12]. Four of the cDNAs were obtained by both 
methods, giving a net result of 14 novel rat Ly49 cDNAs. Of these, 11 exhibited 
complete and three incomplete ORFs.  
 
As a rule, the Ly49 genes have a long 5’-UTR intron 50 -100 nucleotides (nt) upstream of 
the translation start codon, and many, but not all, have a short 3’-UTR intron immediately 
downstream of the stop codon (Fig.1). For the cDNAs cloned by RT-PCR, primers were 
therefore designed to lie close to the predicted translation start and after the predicted 3’-
UTR intron. The larger part of the 5’ and 3’UTR sequences, including the putative first 
exon, is consequently not contained within these cDNAs, and the presence of a 5’-UTR 
unproven (Fig. 1, top). In order to simplify the presentation the first translated exon is 
here referred to as exon 2 for all the genes. A list of the cloned genes is given in table 1, 
along with the previously cloned and the deduced BN genes, in the order they occur in 
the BN genome in the centromeric to telomeric direction. The previously cloned Ly49s3 
(PVG) gene did not match any of the BN sequences, but was most similar to Ly49s4. 
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2.2 Analysis of deduced amino acid sequences 
The translated part of Ly49 genes consists of six exons. Exon 2 encodes the cytoplasmic 
domain, where inhibitory Ly49 receptors have an ITIM motif, characterized by the amino 
acid sequence VxYxxV/L (Fig. 2). This motif was found in 20 of the receptors (including 
the predicted BN sequences) (Table 1). Exon 3 encodes the transmembrane domain, 
where activating Ly49 receptors have an arginine (R) residue, found in 18 of the 
sequences. Five of the receptors exhibited both features. Exon 4 encodes the membrane 
proximal stalk, which probably function mainly as a spacer and in dimer formation. 
Exons 5 - 7 encode the ligand-binding lectin-like domain, characterized by evolutionary 
conserved amino acids with a typical succession of β-strands, α-helices and loops [25;26] 
(Fig.  2). Particularly conserved are the cysteines that form the two disulphide bridges 
between the α1-helix and the β5-strand (in the case of Ly49i8 possibly even three) and a 
single bridge between the beginning of the β3- to the end of the β4-strand. Like some 
other KLR, the Ly49 receptors have an additional disulphide-linked loop at the start of 
the lectin-like domain, formed by the β0- and the beginning of the β1-strand [27]. Eight 
of the predicted sequences may have a fifth intrachain disulphide bond, clamping the end 
of the β5 strand to the basis of the lectin-like domain just below the β0-loop. Ly49i8 
exhibits the most deviant sequence, including 7 amino acids encoded by a short extra 
exon (exon 2b). In the rat genome assembly the extra exon is found approximately 
midway in the ~ 1350 nt sequence separating exons 2 and 3. A novel splice variant of 
Ly49s3 similarly contained a 39 bp/13aa sequence in this position (Fig. 2).  
 
Inspection of the aligned sequences shows that the receptors fall into subgroups with 
shared substitutions compared with the consensus sequence. This is more clearly 
 47
visualized in Fig. 3, where most of the receptors are seen to cluster in three larger 
subgroups, each containing nearly equal numbers of inhibitory (i) and activating (s) 
members (in the case of group I, bifunctional receptors (si) substitute for activating). In 
addition, there is one group with two members, p8 and s2, and three with a single 
member only, all inhibitory (i13, i6 and i8). The dendrogram in Fig. 3 is based on the 
translated part of the genes only (amino acid sequences). The rat Ly49 genes can be 
divided into four major subgroups with respect to their 3’-ends (detailed in legend to Fig. 
1). As indicated in Fig. 3, these coincide with the branching pattern of the dendrogram.  
 
2.3 Physical map 
Ly49 is by far the largest of the multigene subfamilies within the NKC, its 34 loci 
making up half of the KLR genes, spread across the distal ~1.75 Mb of this genetic 
region (Fig.  4a). The genes, all oriented the same transcriptional direction, are regularly 
spaced, with a median size of ~ 22 kb from exon 2 to exon 7 and median distance ~ 51 kb 
between the start codons of contiguous genes. For all the genes, intron 6 (separating the 
exons encoding the middle and last part of the lectin domain) is by far the largest, usually 
> 5 000 nt, in some cases even > 10 000 nt.  
The order of loci deduced from a contig of overlapping BAC clones exhibited complete 
co-linearity with the physical map based on the genome assembly (Fig. 4b). However, the 
325 kb BAC clone AC114442 lacked the Ly49si1 gene, expected to lie in the middle of 
its reported 279 kb contig, and contained only incomplete sequences for si3, i11 and p2. 
Furthermore, in the two BAC clones AC130159 and AC134637 flanking each side of 
AC114422, the hypothetical pseudogenes Ly49p2 and –p3 were positioned close 
together, as local duplicates. In the genome assembly, however, they were assigned 
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positions 190 kb apart. This region displays a repeated pattern with respect to deduced 
receptor function: si3 – i11 – p2 – si1 and si2 – i10 – p3 – si5, (Fig.  4), with si3 most 
closely related to si2, i11 to i10 and si1 to si5 (Fig.  3), and with p2 and p3 closest 
relatives when nucleotide sequences are compared (98 % sequence identity, not shown in 
Fig. 3), including sharing the same defect (missing exons 6 and 7 - table 1). The pattern is 
compatible with a chromosomal segment duplication involving four genes. Segmental 
duplication does not explain, however, the missing parts of AC114442 and the presence 
of both Ly49p2 and -p3 in AC130159 and in AC134637, which according to the genome 
assembly do not overlap (see Discussion).  
 
The Ly49 gene region can be divided into three major subregions or blocks, each 
containing the genes belonging to the larger subfamilies described above (with s2, p5, p8 
and p9 intermingled with the block II genes). The three single gene subfamilies fall 
outside the blocks, with Ly49i13 as the most proximal and Ly49i8 as the most distal gene, 
and Ly49i6 between blocks II and III. In block II sequence similarities between s4 - p7, i4 
- i3, and p5 - p8 (Fig.  3) suggest segmental duplication involving three genes.   
2.4 Allelic variation  
Considerable allelic variation with respect to gene content and sequences has been 
reported for the mouse Ly49 gene region [28-31]. Although a high resolution map of this 
genetic region is yet only available in the rat for the BN strain, extensive allelic variation 
can be deduced by sequence alignments with cDNA data derived from other rat strains. 
Of the 21 cDNAs hitherto cloned from the PVG, DA or F344 strains, the majority were 
polymorphic at the DNA level when compared with their BN alleles (table 1). Seventeen 
seem to be functional in the strain from which it was cloned, as inferred from a complete 
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ORF and mRNA expression. Of these, six are predicted to be non-functional in the BN 
strain: one (Ly49s3) is missing from the BN genome and five have inactivating mutations 
(nonsense or frameshift – Ly49si3, -s5, -s4, -i2, -s7) (for -s5 confirmed by cDNA 
sequencing of the BN allele, for the others by the presence of the mutation in at least two 
independent genomic trace sequences, except for s4 where only a single trace sequence 
was found). According to the sequence of BAC clone AC125741 and the genome 
assembly, a seventh gene, Ly49i5, lacks the last coding exon. However, the untranslated 
3’-UTR exon 8 is present in the clone AC119655, and a complete cDNA was obtained by 
RT-PCR on BN NK-cell mRNA (Dai, KZ – personal communication).  
 
One of the previously cloned genes (Ly49p8) had multiple defects, found also in the 
deduced BN allele. Three cloned cDNAs were incomplete: Ly49s8(DA) Ly49s6(PVG) 
and Ly49i9(PVG) (Table 1). All three clones of Ly49s8(DA) shared the same defect, as 
did two independent clones of Ly49i9(PVG). RT-PCR of Ly49s6(PVG) gave only 
truncated products. The defects are therefore likely to be real. Both the BN and the PVG 
Ly49s6 are probably non-functional, but for different reasons (Table 1). As the causes of 
the splicing defects are unknown, faulty splicing due to cryptic splice sites remains a 
possibility also for the Ly49s8 and the Ly49i9 alleles. We have, however, chosen not to 
assign these genes pseudogene labels (see Discussion). 
 
2.5 Phylogenetic analyses 
As detailed above, whereas NK alloreactivity seems to be regulated primarily through 
inhibitory receptors in man and mouse, allospecific activating receptors seems to be 
equally important in the rat. With the mapping of the functional ‘alloreactivity’ gene Nka 
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to the distal part of the Ly49 region of the rat NKC [12], it would be of interest to 
compare this genetic region in the mouse and the rat. Furthermore, whereas rodents have 
many Ly49 genes, the species so far investigated in primates, carnivores (dog, cat) and 
artiodactyls (cow, pig) have only one [15;32], although perissodactyls (horse) have at 
least six [33]. Phylogenetic analyses of these mammalian orders showed that the primate 
Ly49 genes were more closely related to those from carnivores and artiodactyls, than 
those from the mouse [32], which contrasts with other genes, where molecular 
phylogenetics has placed primates closer to rodents [34;35]. The dendrogram in Fig. 5 
shows that also the rat, together with the mouse genes, segregate from those of the other 
mammalian orders in a distinct clade.  Equally striking is the lack of overlap between the 
mouse and the rat genes. Only rat Ly49i8 and mouse Ly49B form a clear-cut orthologous 
pair, with the most telomeric position in both species. Furthermore, the most centromeric 
mouse gene, Ly49Q, is more closely related to the rat genes (encoded by block I), than to 
other mouse genes, and vice versa for rat Ly49i6, which maps between blocks II and III. 
For all the other genes, the intraspecific similarities are greater than the interspecific, 
confirming the dynamics of this genetic region.    
 
2.6 Recent duplications or gene homogenization? 
The closer intraspecific sequence similarities for the majority of the genes could be due to 
duplications after the split between mouse and rat ~40 million years ago, or result from 
homogenization events, or both. Evidence for the latter mechanism emerges when the 
genes are compared exonwise (Fig. 6). When comparing exon 2, inhibitory receptors tend 
to cluster separately from activating and bifunctional. When comparing exon 5, however, 
smaller groups are formed, in most cases containing both inhibitory and activating 
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members (or bifunctional instead of activating members). Fig. 7 shows a closer view of 
eight selected receptors, four presumed activating and four inhibitory, exhibiting 
particularly distinct homogenization patterns. For the first two translated exons, the 
inhibitory receptors are more similar to each other than to any of the activating, in some 
case even exhibiting complete sequence identities. For the third exon (encoding the stalk) 
this pattern is broken, and for the last three translated exons (encoding the ligand-binding 
domain), activating and inhibitory receptors form closely related pairs, with complete 
sequence identities for some of the pairs. This pattern of ‘split homogenization’ could be 
explained by gene duplication followed by deletion of the chromosomal segment between 
e.g. introns 2 of neighbouring receptors of opposite signalling functions. However, this 
cannot explain the homogenization observed with other genes, such as Ly49s6 and 
Ly49i2, mapping far from each other. It should be noted, however, that the pattern is only 
seen between genes within one of the three major blocks.   
3 Discussion  
We here present evidence of 34 rat Ly49 loci in the BN genome, of which 15 seem to be 
pseudogenes in this strain. Some of these may be erroneously categorized as pseudogenes 
due to sequencing errors or incomplete sequences. However, the presence of multiple 
independent sequences from the genomic trace archive showing the same nonsense or 
frameshift mutations suggests that most are real, and for Ly49s5 the nonsense mutation 
has been confirmed by cDNA sequencing of the BN allele (Naper, manuscript in 
preparation). In the case of missing exons, the presence of multiple gaps in the BAC 
clone sequences and the genomic assembly make faulty categorization as pseudogenes 
more likely. This is evidently the case for Ly49i5, where the BAC clone used for 
sequencing (AC125741) exhibits a ~ 600 nt gap 8kb downstream of exon 6, which is the 
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expected region of this exon. Here, a complete cDNA was obtained by RT-PCR of BN 
NK cells (see note to table 1). The cDNA cloning of Ly49 genes from other inbred strains 
(PVG, DA, F344) furthermore reveals that many of the predicted pseudogenes in the BN 
rat probably are functional in the other strains. Ultimately, whether the genes are 
functional or pseudogenes must be determined at the protein level, which so far only has 
been done for Ly49i2 [36], -s3 [37], -i4, -i5 and -s5 (Naper, manuscript in preparation). 
By the less stringent criteria of complete ORFs and mRNA expression in the case of the 
cloned genes, or complete ORFs constructed from the genomic sequence in the case of 
the BN alleles, as many as 26 of the rat genes may be functional, a figure that may get 
higher when genes from other laboratory strains and wild rats are investigated. (Note that 
we have chosen not to label Ly49s6 a pseudogene, although the defect in the cloned PVG 
allele makes it likely to be non-functional.) 
As for the number of genes, a caveat should be made for the apparent duplicated four-
gene segment in block I, as it proved impossible to construct a consistent gene order for 
the three overlapping BAC clones AC130159, AC114442 and AC134637. Persistent 
heterozygosity could be an explanation, although the possibility seems remote on the 
background that the BN rat substrain selected as the sequencing target 
(BN/SsNHsd/Mcw) was subject to 13 additional generations of inbreeding to ensure 
homozygosity [24].  
 
Of the 26 putative functional receptors, 13 are predicted to be inhibitory and 7 to be 
activating (the eighth activating receptor, Ly49s3, is not represented in the BN genome). 
There are in addition five predicted receptors with both ITIMs and an arginine in the TM 
domains. Such Ly49 variants have not previously been reported, and their signaling 
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properties are yet unknown. The clustering of inhibitory and activating receptors into 
groups with closely related lectin-like domains (Figs. 6 and 7) (recently also reported by 
Hao & Nei [38]), can be intepreted as evidence for functionally ‘opposing pairs’ 
recognizing the same ligand. As ‘bifunctional’ receptors substitute for activating in some 
of these groups, a prediction would be that they at least transmit activating signals 
(currently under investigation). 
 
As for the genomic organization, the division of the genes into three major blocks 
encoding related receptors is striking. To a certain extent it may reflect recent 
duplications of individual genes, or as in the case of block I and possibly block II, 
duplications of chromosomal segments bearing more than one gene. No doubt 
expansions/contractions of the gene region through duplications/deletions as well as 
homogenization by gene conversion contribute to rapid evolution of this gene region, as 
reflected by the great interspecific sequence differences between the rat and the mouse 
[32]. It is noteworthy that gene homogenization seems restricted to genes within the same 
block, although they can be spaced far apart from each other within the block.  
The close sequence similarities shared by members of the multigene families within the 
NKC may not necessarily reflect recent duplications, but rather genes that have not yet 
escaped homogenization. It is possible that the lack of homogenization observed between 
the three Ly49 blocks is an expression of incipient escape, so that with time the three 
blocks will drift apart into separate subfamilies, but inside each block retain their 
sequence similarities due to continued homogenization.  
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The Ly49 gene region is flanked by Ly49i13 proximally and Ly49i8 distally, both falling 
outside the major blocks. The latter has the most deviant sequence of all the Ly49 genes. 
In particular is the last part of the lectin-domain different from other Ly49 genes, 
suggesting different ligand-binding properties, which may be linked to its chromosomal 
position outside the blocks, non-participation in gene homogenization and retention of 
sequence similarity with its murine ortholog, Ly49B. Identification of its ligand will 
clearly be highly informative. It should be added that the additional seven amino acids 
inserted between the cytoplasmic tail and the TM-region in Ly49i8, encoded by a 
separate exon (exon 2b), is not present in the orthologous mouse Ly49B receptor. It 
probably represents a splice variant rather than a splice artifact, as a splice variant with 
39bp/13 aa, encoded by a similar exon 2b, also was observed for Ly49s3. Furthermore, 
also the rat Nkg2d (= Klrk1) gene contains a small (39 bp) intron in this position [39]. 
 
Another structural feature deserving comment is the high number of intrachain disulphide 
bonds in the lectin domains of Ly49 receptors. The CLSF receptors usually have two 
intrachain SS-bonds stabilizing the lectin domain. Like many other CLSF members, the 
Ly49 receptors have in addition a third at the base of the domain. Characteristic for the 
Ly49 family, however, is a second disulphide bond between the α1-helix and the β5-
strand and many of the rat receptors are in addition predicted to possess a fifth SS-bond 
between the end of the β5-strand and the base of the lectin-like domain (Fig.  2). Soluble 
forms of the Ly49 receptor ligands, MHC class I, seem to abound in the body fluids [40]. 
In order to strip off bound soluble ligands, the Ly49 receptors may be subject to frequent 
acid rinses by recycling via early endosomes, which may be a reason why Ly49 receptors 
need the extra SS-bonds for added stability. 
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Comparisons with the cloned genes from the PVG, DA and F344 strains with the 
predicted genes from the BN strain bear evidence of extensive allelic polymorphism. The 
near complete segregation of the rat and mouse receptors in phylograms further 
underscores the rapid evolutionary change of this genetic region. Rapid evolution is also 
observed for two other immunoreceptor encoding genetic regions, the human leukocyte 
receptor complex (LRC), encoding KIR/LIR and related Ig-like receptors [41], and the 
MHC (as recently described for the rat in [42]). These three gene complexes have in 
common that they encode non-rearranging receptors. In order to keep pace with rapid 
microbial evolution, considerable plasticity seems required, with expansion/contraction 
through repeated unequal crossing-over events and gene conversion as central 
mechanisms. The importance of gene conversion in MHC evolution is debated, in 
particular whether it functions as an adaptive mutator under selection (the ‘strong’ model) 
[43]. In the case of the Ly49 region (and the LRC) we argue for a strong model. The 
Ly49 (and the KIR/LIR) receptors differ from the MHC in that they are signaling 
receptors with activating as well as inhibitory members. According to current orthodoxy 
in NK-cell target recognition, rooted in the strong position of the missing self-hypothesis 
[44], inhibitory Ly49 receptors are ascribed supremacy, with activating variants 
considered evolutionary afterthoughts. For example, with pairs of opposing Ly49 
receptors recently described with near identical lectin domains and shared ligand 
specificities [45;46], the activating variants were proposed to have arisen from the 
inhibitory through gene conversion as a result of pathogen-driven selective pressure [47]. 
In the recently characterized bony fish NKC [48], however, the majority if not all cloned 
receptors lacked ITIMs and possessed an arginine in the TM region, predicting activating 
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function [49]. For functionally related receptors, like CD94/NKG2 and KIR/LIR and PIR, 
a recurrent finding is the existence of pairs of opposing receptors with shared ligand 
specificities. If, as argued above, the ‘bifunctional’ rat Ly49 receptors have activating 
properties, the rat possesses a near balanced repertoire of activating and inhibitory Ly49 
receptors, forming smaller subgroups with opposing receptors with closely related lectin-
like domains. On this background, a reasonably interpretation seems to be that the system 
is designed so that receptors of opposite signaling functions shall recognize the same 
ligands. Gene conversion then seems to represent a particularly suitable mechanism to 
ensure that the opposing receptors keep pace with each other in chasing the rapidly 
evolving ligands. Why we should have a system of pairs of opposing receptors is still a 
puzzle. It may e.g. make the system more robust against pathogen exploitation or allow 
for more accurate estimation of ligand densities. A corollary is that the activating Ly49 
variants have a more central role than previously thought, compatible with observations 
made long ago in the rat that target allospecificities can trigger allorejection involving 
Ly49 receptors [12;21-23].   
 
PVG NK cells recognize and rapidly eliminate allogeneic bone marrow derived target 
cells, discriminating between BN, AO and DA targets [50]. In contrast, although DA NK 
cells efficiently lyse tumor cell lines, they are inert towards allogeneic targets. This 
genetic difference was the basis for defining the alloreactivity gene, Nka, which was 
mapped to the distal part of the Ly49 gene region [12]. As the associated structural gene 
seemed to activate alloreactivity [12], most likely by encoding an activating receptor, it is 
noteworthy that the (purely) activating receptors all map to the distal part of the Ly49 
region and exhibit particularly high allelic polymorphism. Of eight putative activating 
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receptors, only Ly49s1 and –s2 seem to be functional in both the strains investigated so 
far. Ly49s3, which is an important activating alloreceptor in the PVG strain, has no 
counterpart in the BN genome. Ly49s4, -s5, -s6 and -s7 have inactivating mutations in 
the BN strain, and the DA Ly49s8 is subject to faulty splicing. The activating receptors 
thus seem particularly vulnerable to inactivation by mutation, at least in inbred strains 
kept under laboratory conditions. The clustering of receptors with opposite signalling 
functions together in subsets with similar lectin domains (as argued above, suggesting 
shared ligands), probably constitutes the physical substrate underlying the capacity of 
PVG NK cells to discriminate between different MHC encoded allospecificities. An 
intriguing possibility is that the structural gene associated with Nka is not a single gene, 
but several of the genes encoding activating Ly49 receptors, each contributing to the 
general loss of alloreactivity observed in DA NK cells. A prediction would be that DA 
NK cells express few if any functional activating Ly49 receptors. We have previously 
shown that DA NK cells do indeed have very low expression levels of Ly49 genes [12], 
possibly reflecting a limited repertoire of expressed genes. On this background, it is 
noteworthy that the only activating DA Ly49 gene cloned seems to be non-functional.   
 
In conclusion, our findings demonstrate a highly dynamic genetic region, containing a 
large number of closely related immunoreceptors, with the highest number of Ly49 genes 
in any species reported so far. However, rather than considering this an anomaly, the high 
gene content of the rat Ly49 gene region seems to offer a rich source for further 
explorations into the properties and evolution of a gene complex encoding non-
rearranging immunoreceptors. The complex seems designed not only to meet the major 
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challenge of chasing rapidly evolving ligands, but to do so in step for pairs of receptors of 
opposing signalling functions.   
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4 Methods 
4.1 Ly49 Homology screening 
The cDNA library was from a subset of PVG NK cells (KLRH1+) and has previously 
been described, except that primary cDNA was ligated into the ZAP Express vector 
instead of into pMET7 [51]. Complexity of the primary library comprised more than 
2x106 clones. 500,000 pfu of primary cDNA library were plated out on 160 mm NZY 
agar plates at a density of 50,000 pfu/plate. Replica nitrocellulose filters were lifted from 
each plate, denatured according to the manufacturer’s instructions (Stratagene), rinsed in 
0.2M Tris-HCl (pH 7.5) and 2x SSC buffer, and blocked in hybridization solution (6x 
SSC, 5x Denhardt’s, 0.5% SDS, 20 µg/ml sonicated salmon sperm DNA, 50% 
Formamide). Hybridization was performed with a combination of [32P]-dCTP labelled 
cDNAs from rat Ly49i2, rat Ly49s1 (Ly49.29), rat Ly49s2 (Ly49.12) and mouse Ly49H 
overnight at 42oC. The filters were then washed twice with 2x SSC, 0.1% SDS and twice 
with 0.5 SSC, 0.1% SDS and films were developed after 3 days of exposure at 80oC. The 
plaque lifts were oriented and crosshybridizing plaques were purified to homogeneity.  
Clonal phage stocks were processed into PBK-CMV phagemids by in vivo excison 
according to the manufacturer’s instructions (Stratagene).  Both strands of cloned cDNAs 
were sequenced in PBK-CMV by automated fluorescent sequencing at the UCSF Cancer 
Center molecular biology core facility. In this way eight new genes were obtained: 
Ly49s4, -s6, -s7, -i4, -i5, -i6, -i8 and -i9, plus the PVG allele of Ly49s2 previously cloned 
from the F344 strain [12].   In an alternative expression-based cloning strategy a ninth 
gene was also isolated, Ly49s5 (Naper, manuscript in preparation). 
 
4.2 Identification of Ly49 genes from BAC clones and the genomic BN sequence  
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New Ly49 exons were identified by sequence similarity search (using the NCBI BLAST 
program) of BAC clones (listed in Fig.  4) and the whole genome sequence 
(www.ensembl.org/ Rattus_norvegicus) against previously sequenced Ly49 cDNA 
sequences. Exon-intron splice junctions were deduced (following consensus rules for 
splice junctions and for intron phases of group V C-type lectins [39]), contiguous exons 
joined and the resulting sequences translated and compared with previously known 
proteins. Sequences containing all six coding exons giving complete open reading frames 
were defined as potentially functional genes. Sequences with nonsense or frameshift 
mutations or lacking exons were considered to be pseudogenes.  
 
4.3 Cloning by RT-PCR  
Primers were designed in the putative 5’ and 3’ untranslated regions (UTR) of the 
potentially functional genes and used for RT-PCR on mRNA isolated with Dynabeads 
mRNA Direct kit (Dynal Biotech) from DA or PVG LAK cells (lymphokine activated 
killer cells, i.e. NK cells cultured for ~10 days in the presence of interleukin-2). First 
strand cDNA synthesis was carried out with M-MLV reverse transcriptase RNase H 
(Promega) using 1 µg total RNA in a 20 µl reaction volume. The PCR products were 
analyzed by gel electrophoresis. Bands of expected lengths were excised from the gels, 
amplified by cloning (TOPO TA cloning kit, Invitrogen) and the inserts sequenced from 
both ends (MediGenomix, Germany), with internal sequencing primers generated to get 
full sequences in both directions. Ten new genes were detected: Ly49si1, -si2, si3, -i3, -
i7, -s8, -s7, -s4, -i5, -i4, of which the latter four also were obtained by homology cloning, 
as described above. Three independent clones of the first six were fully sequenced in both 
directions.  
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4.4 Gene mapping and biocomputing 
In silico analyses of rat, mouse and human genomic sequences were performed by 
pairwise BLAST against BAC clones and by sequence comparisons (BLAST) followed 
by visual inspection of the annotated rat genome (the analyses continually updated 
against the latest version, currently v. 21.3b.1, 8 February 2004). Biocomputing, 
including sequence analysis, was performed using software supplied by the Norwegian 
EMBNet node at the Biotechnology Centre in Oslo, Norway. The presented dendrograms 
were generated using the pileup program in the GCG package version 8.0. Alignments 
were also generated by using the program CLUSTAL X [52], and analyzed with the 
neighbor-joining method [53]. Bootstrap values were computed with 1000 iterations.  As 
the two methods yielded the same major branches, only the figures from the GCG 
package are presented here.  
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Figure legends 
 
Fig. 1 
Intron-exon structure of rat Ly49 genes. Boxes indicate exons, numbered as indicated 
below the boxes, with white showing translated and gray untranslated parts. Translated 
parts of the protein shown below the figure: cyt - cytoplasmic domain, TM - 
transmembrane part, stalk - membrane proximal stalk, pLD, mLD and dLD - proximal, 
middle and distal part of lectin domain. ATG - start codon. Stop - stop codon. The figures 
following the stop indicate length from stop codon to 5-‘UTR intron and typical length of 
intron. The four 3’-UTR patterns shown are shared by multiple genes with gene name of 
typical member shown below type designation. Although positions and length may vary 
slightly, the sequences of the 5’-UTR introns are highly conserved within each group 
(generally > 90 % identity). The patterns concur with chromosomal positions (as divided 
into segments or blocks - see fig 4), as follows: Type 1 genes: all block I encoded genes 
(top). Type 2 genes: four genes within block II (s2, p5, p8 and p9). Type 3 genes: All the 
genes within block III. Type 4 genes: The remaining genes in block II and Ly49i8. The 
most centromeric gene, Ly49i13, has a longer intron, but conserved the flanking parts of 
the adjacent type I genes. Ly49i6, situated between blocks II and III, has an 227 nt intron 
10 nt downstream of the stop codon. For the genes not cloned the introns were deduced 
from the rat genome sequence. 
 
Fig.  2 
Alignment of predicted amino acid sequences for all cloned rat receptors, except 
Ly49s5(PVG) (Naper, in preparation), and the two incomplete cDNAs Ly49s8(DA) and 
Ly49i9(PVG). The less informative sequence of the long stalk region has for practical 
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reasons not been included. Con - consensus sequence. TM region underlined. Predicted 
N-glycosidation sites boxed. Numbers on top of exons 5 - 7 indicate cysteine pairs 
involved in intrachain disulphide bonding. Bottom line: conserved secondary structures 
(α-helices, β-strands and loops) of the C-type lectin domain [25;26]. Exon 2: The residues 
forming the ITIM motif (VxYxxV/L) of predicted inhibitory receptors are shown in bold 
on the top line and in the consensus sequence. In the receptor sequences, amino acids 
replacing these residues are shown in bold. Exon 3: Similarly shown in bold in the 
sequences are the residues departing from the arginine (R) in the TM region, 
characteristic of activating receptors. The nomenclature is based on the principle 
introduced by Naper et al [36;37]. (Predicted) inhibitory receptors are called Ly49in (i - 
inhibitory, n - number assigned in the order the genes were first described); stimulatory 
receptors Ly49sn; ‘bifunctional’ Ly49sin; pseudogenes Ly49pn (numbered according to 
chromosomal position). The letters refers to the strain from which the gene was cloned: F 
- F344, P - PVG and D - DA. Accession numbers: Ly49i3(DA) - AY659932, 
Ly49i4(PVG) - AY649834, Ly49i5(PVG) - AY653729, Ly49i6(PVG) - AY651018, 
Ly49i7(DA) - AY659934, Ly49i8(PVG) - AY649835, Ly49i9(PVG) - AY649839, 
Ly49s2(PVG) - AY649838, Ly49s4(PVG) - AY649831, Ly49s6 (36) - AY649837, 
Ly49s7 - AY649833(PVG), Ly49si1(DA) - AY659935, Ly49si2(DA) - AY659933, 
Ly49s3(PVG) splice variant - AY747628, Ly49si3(PVG) - AY653730. The protein 
coding part of additional sequences predicted from the BN rat genome to encode 
functional genes (rLy49i9, i10, i11, i12, i13, s5, s8, si4 and si4) can be downloaded from 
http://www.med.uio.no/imb/anatomi/immunobiolab/fossum/index.html 
Fig. 3 
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Phylogenetic tree (dendrogram) based on deduced amino acid sequences of presumed 
functional receptors (bootstrap values, 1000 iterations) in per cent shown for the main 
branches only). Three of the clusters contain multiple genes. In addition there is one with 
two genes (p8 and s2) and three single gene families (i13, i6 and i8). The groups coincide 
with gene localization, defining three chromosomal blocks, denoted I, II and III (see 
physical map). Each block contains inhibitory (i) and activating (s) or bifunctional (si) 
members. Following the submission of our manuscript, two papers were published on in 
silico deduced Ly49 sequences from the rat genome [38;54], with predicted receptors 
named in consecutive order from the telomeric end, permitting gene identification [38]. 
The predicted phylogenetic tree in [38] is highly similar to the one presented here, with 
the reservation that i13 was not reported and p1 - p4 and i5 were omitted (i5 classified as 
a pseudogene), whereas the predicted pseudogenes p1 - p7 are omitted here.  
 
Fig.  4 
A. Physical map of the Ly49 region, with position of loci as deduced from the rat genome 
sequence (Ensembl release 19.3b.2 - February 2004), but with naming of the genes a 
composite of results derived from four different strains, with presumed functional genes 
in the PVG, DA or F344 given priority over apparent pseudogenes in the BN strain (cf. 
table 1). Arrows indicate transcriptional orientation with lengths corresponding to 20 kb. 
Vertical boxes represent individual exons. Numbers below boxes indicate genomic 
position of the first coding exon - exon 2 (to be added to the number on the left - e.g. 
Ly49i13 at position 167 Mb + 425 kb = 167 425 kb from the centromere). The related 
genes clustering in the three major groups in the phylogram (Fig. 3) are here shown to 
map together, defining three major blocks, named I, II and III, with Ly49i13, -i6 and -i8 
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falling outside the blocks. Deduced functional properties according to the presence or 
absence of ITIMs or charged amino acid (arginine) in the TM domains indicated by -: 
inhibitory, +: activating, +/-: bifunctional, p: pseudogene. Gene names as explained in 
Fig. 2, letter in parenthesis rat strain from which the gene was cloned: F- F344, P - PVG, 
D - DA, *(B) -  not yet cloned, sequence in silico deduced from the BN rat genome 
sequence.   B. Physical map of rat Ly49 genes as deduced from overlapping BAC clones. 
The line segments indicate the BAC clones. ● indicates the presence of the gene in the 
BAC clone, semicircle that only some of the exons are present.  
 
Fig.  5 
Dendrogram of all Ly49 molecules (amino acid sequence of the whole proteins) from rat 
(r), mouse (m), human (hs), dog (cf), cat (fc), baboon (ph), pig (ss), cow (bt) and horse 
(ec). Only mLy49B and rLy49i8 bear clear-cut evidence of orthologous relationship, 
underscored by the encoding genes mapping to the same localization at the distal end of 
the gene clusters in the two species. The majority of the rat and mouse Ly49 receptors 
cluster in separate branches (i.e. exhibit greater intraspecific than interspecific sequence 
similarities) indicating post-speciation subfamily expansions by gene duplications or 
gene homogenization by gene conversion. The exceptions are mLy49Q and rLy49i6. 
Bootstrap values for main branches only (in percent after 1000 iterations). The almost 
complete separation of the mouse and rat receptors, with the exceptions noted here, were 
also reported in [38;54]. 
Fig.  6 
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Dendrograms of exon 2 and exon 5 (deduced amino acid sequences) of the rat Ly49 
genes. The peptide sequences encoded by exons 2 and 3 are involved in signal 
transduction, by exons 5 - 7 in ligand binding. Only bootstrap values > 80% shown.  
 
Fig.  7 
Dendrograms based on exonwise comparisons on the six translated exons of four selected 
inhibitory and four activating receptors.  
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 Table 1. Overview of rat Ly49 receptors.  
* Identities based on nucleotide sequences of coding parts, disregarding missing parts. **Ly49s5(PVG), 
obtained by expression cloning, has by functional studies been confirmed to encode a stimulatory receptor 
(Naper et al. In preparation). *** Full length clone with all six coding exons has been obtained by RT-
PCR on mRNA from BN rat NK cells (Dai, KZ – personal communication).
N
o 
Name Strain 
cloned 
Identity 
to BN * 
Signaling 
motif 
Predicted 
function 
Comments 
1 i13   ITIM inhibitory  
2 p1   - non-functional Multiple defects, including missing 
exon 2 and exon  3 
3 i12   ITIM inhibitory  
4 Si3 PVG 99.4 % ITIM/TM-R bifunctional BN nonsense mutation exon 5 
5 i11   ITIM inhibitory  
6 p2   ITIM non-functional Missing exons 6 and 7 
7 Si1 DA 99.7 % ITIM/TM-R bifunctional  
8 Si4   ITIM/TM-R bifunctional  
9 Si2 DA 99.9 % ITIM/TM-R bifunctional  
10 i10   ITIM inhibitory  
11 p3   ITIM non-functional Missing exons 6 and 7 
12 si5   ITIM/TM-R bifunctional  
13 i9 PVG 98.6 % ITIM inhibitory PVG cDNA lacks exons 6 and 7 
14 p4   TM-R non-functional Missing exon 5 
15 s5 PVG** 97.4 % TM-R activating BN nonsense mutation exon 5 
16 i5 PVG 99.7 % ITIM inhibitory BN lacks exon 7*** 
17 s2  (.12) F344/ PVG 99.9 % TM-R activating  
18 s6 PVG 99.8 % TM-R activating PVG cDNA lacks exon 4 and part of 
5. BN frameshift mutation exon 6 
19 s4 PVG 99.9 % TM-R activating BN nonsense mutation exon 6 
20 i4 PVG 96.2 % ITIM inhibitory  
21 p5   TM-R non-functional Frameshift exon 3, nonsense exon 4 
22 p6    non-functional Lacks ITIM and TM-R. Multiple 
other defects. 
23 p7   TM-R non-functional Nonsense mutation exon 6 
24 i3 DA 99.7 % ITIM inhibitory  
25 p8  
(.19) 
F344 99.9 % TM-R non-functional Multiple defects in F344 and BN, 
incl. exon 2 frameshift mutation   
26 i2 PVG 99.3 % ITIM inhibitory BN exon 5 nonsense mutation  
27 p9   TM-R non-functional Multiple defects 
28 i6 PVG 99.1 % ITIM inhibitory  
29 s8 DA 100 % TM-R activating DA missing exon 3 and first part of 
4, with frameshift splicing 2 to 4 
30 s7 PVG 99.4 % TM-R activating BN exon 4 frameshift mutation  
31 s1  (.29) F344 99.5 % TM-R activating  
32 i1  (.9) F344 100 % ITIM inhibitory  
33 i7 DA 100 % ITIM inhibitory  
34 i8 PVG 100 % ITIM inhibitory  
 s3 PVG  TM-R activating Closest relative Ly49s4 ~ 96.2 % 
sequence identity 
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Fig.  1 
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Fig. 2 
     
EX2      VxYxxV/L                          EX2b          EX3               R 
Con MSEQEVTYSTVRFHKSSGLQNQVRPEETQRPREAGHRE               CSVPWQLIVIALGILCSLRLVTVAVLVTNI 
i4P  -T------T--------VF--K--S-D-RSAK-N----               S----K-----------VLM----A----- 
i3D  -T------T--------VFH-K--SK--LSAK-N----               S----K------A----VLM----A----- 
s3P  --K-D-PC-----K------Y--------------W-. GNNSCHQKMNSPN ..-----T---T---L-----A--M----- 
s4P  --K-D-PC-----K-----WY------------T-CR.               ..-----T--GI---L-----A--M-L---  
i5P  -T------T--------VF--E--S----SAK-I----               S----K----------L-L----------- 
i2P  -T------T--------VF--E--S----SAK-I----               S----K-----------VL----------C 
s6P  --K-D-PC-----K-----LY--------------C-.               ..-----T---I---L-----A--M----S 
si1D ------S--N---K-C--------------A-A-----               R--------V--V--------A--IF---- 
si2D ------S--N---Q-C-D------------A-A-----               R--------V--V--------A-VMF---- 
si3P ------S--N---Q-C-D------------A-A-----               R--------V--V--------A--MF---- 
s7P  ------IF--E------------------WS-K--P-V               ----CL--------..P----IA-A--SH- 
s1F  -N----IF--E------------------SS-K--P-V               ----CL--------..P----IA-A--SH- 
i1F  ---------S---S---------K----KG-K------               -Y---H----------T-L-L-------I- 
i7D  ---------SL--S---R-H---K----RG-R------               -Y---H----------T-L----------- 
i6P  -CD-------------------E-A----G-I-----K               ---L--H-K--------HL---L---ALS- 
s2F  -N--RF-F--A------V----E-T-------K--N-.               ..-C--IT-T------FF---S---M-I-- 
p8F§ -N--R--F--A---N--V----E-T-GDSEA*KSWKQ.§           §* ..-C--ST-T-------F---S-----KT. 
i8P  --------T-------P---------------K----A    HSECKVRE   ---T-KP---V-------L-------L-HI 
 
EX5  5      4    4            1   2              EX6       
Con KCVEMHWFCYGIKCYYFIMDIKTWHECKQTCQNYSLSLLKIDDEDEL KFLQDQVIRDNYWIGLSYNKEKKEWSWIDNGPSEL 
i4P  G-D--------------T---RI--------------F-----K--- -----HI--------S---NK---------S-FN- 
i3D  R-D--------------T---RI-R----I-------F-----K--- -----HI--------S---NK---------S-FN- 
s3P  G-D--------------T---RI-R------------F-----K--- -----HI--------S---NK----A----S-FD- 
s4P G-D--------------T---RI-R------------F-----K--- -----HI--------S---NK---------S-FN- 
i5P  R--------H-----------R------------N--F-----K--- ----EHF--ES--------NI---------S-LNC 
i2P  G------L----------I-KR---K-I---------F---H-K--- -----HI---S--------NN---------T-LNC 
s6P  G------L------------KR--RK-I---------F---H..... -----HI---S--------NK---------T-LNC 
si1D -N--IY------------L-T-A-NG------DS------------- ---RF--LS-Q---------RE-K-------Q-EF 
si2D -N--IY------------L-K---IR-Q-A--KSR------------ ----L--LS-Q---------A-E--------Q-EF 
si3P -N--IY------------L-K---IR-Q-A--KSR------------ ----L--LS-Q---------A-E--------Q-EF  
s7P  SEI-TY----------V-K-G-S-D--------S--F---------R ----Q-L-P------F--D------A--E----K- 
s1F  SEI-TY----------V-K-G-S-D--------S--F---------R ----Q-L-T------F--D------A--E--HLN- 
s1F  SEI-TY----------V-K-G-S-D--------S--F---------R ----Q-L-P------F--D------A--E----K- 
i7D  NEI-T-------------K-R----G--RI---SN-----------R ----Q---P---------E---NK-A--E----E- 
i6P -G-KI--------------VK-S-NG-Q-----S--P-----H-E-- ----IR--S-------K-HN-E-G-A-T---E-K- 
s2F  RG------------------R---SG-T-----F--P--T------- M--HLL-TP-S-------DNK-SD-T----N--K- 
p8F  RG--I------ME--H----R---SGYS--------A--A------- L--HLL-TP-S-----F-DST-SD-T----N--E- 
i8P  -Q--G----C-M------T-NVQ-NG---I--AC------------M N--KS-LQGKRY----T---SP-KQQ--GDP-.K- 
           --β0-- ----β1----   ---α1---           ---α2---       -β2-- --L1(β)-- -L2- 
  
EX7              3            3     1 2           5   
Con DLNARKYNEKTGGCVFLSKTRLENDDCGNRYPCICEKRLDKFPDPLCSVKERSQSAV 
i4P  -FV--NSLR---Y-MYF-MAG-HD----K--L-----GM--I-A-------T-H--- 
i3D  -FV--TLLR---Y-LYF-MSG-HD----K--L-----GM--I-A-------T-H--- 
s3P  -FV--TLLR---Y-LYF-MSG-HD----K--L-----GM----A-------T-H--- 
s4P -FV--NSLR---Y-MYF-MAG-HD----K--L-----GM--I-A---------H--- 
i5P   --L-C-PLQ---Y-IYF-M-G-HY----K-HL-----GM--ITA------------A 
i2P   --V-MISLH---N-KYF-M-G-HD----K-HL-----GIE-Y-A------------L 
s6P   --V-MISLQ---N-KYF-M-G-ND----K-HL-----GIE-Y-A-----N------L 
si1D  S--LK---V-D-E-M----M----AK-M-PFP---Q-------H 
si2D  S--LK-----Y---M---Q-----AM-M---P---Q---E---- 
si3P  S--LK-----Y---M---Q-----AM-M---P---Q---E---- 
s7P   AS-TM-F-K-L-----------D-T--I-L-S---G-K-N----L-SN 
s1F   PS-TM-F---L-----------DHT--I-L-S---G-K-N----L-SN 
i1F   AS-TM-F-K-L-----------DHT--I-L-S---G-K-N----LPLQLVLK 
i7D   AS-TKIF--RD-A-------K-DSI--N-L-S---G---N----L-FNEC 
i6P   V-SR--F-L-D--------RR---TK-D-S-S---G-T-----G 
s2F   A--T----I-D-----------D-IN-D-LFS---G-------- 
p8F   A--T----V-D-V-----------IN-DYLFN---G-------- 
i8P   -VAGVNLGHDR-N-A---SFQID-E--AKTCG-------NIF-ILVTCVNQRKQLDLQSDEGESEEMYLT 
           --L3--  --β3-- --β4---  ----β5----- 
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